UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

MARK ONE

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the Quarterly Period ended September 30, 2024;

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

for the transition period from ________ to ________

 

ZION OIL & GAS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   20-0065053
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
12655 N Central Expressway, Suite 1000, Dallas, TX   75243
(Address of principal executive offices)   Zip Code

 

(214) 221-4610

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No

 

As of November 5, 2024, Zion Oil & Gas, Inc. had outstanding 934,359,384 shares of common stock, par value $0.01 per share.

 

 

 

 

 

INDEX PAGE

 

    Page
PART I — FINANCIAL INFORMATION
     
Item 1 – Financial Statements – Unaudited    
     
Consolidated Condensed Balance Sheets – September 30, 2024 and December 31, 2023   1
     
Consolidated Condensed Statements of Operations for the three and nine months ended September 30, 2024 and 2023   2
     
Consolidated Condensed Statement of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2024 and 2023   3
     
Consolidated Condensed Statements of Cash Flows for the nine months ended September 30, 2024 and 2023   5
     
Notes to Consolidated Condensed Financial Statements   7
     
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations   38
     
Item 3 – Quantitative and Qualitative Disclosures About Market Risk   47
     
Item 4 – Controls and Procedures   47
     
PART II — OTHER INFORMATION
     
Item 1 – Legal Proceedings   48
     
Item 1A – Risk Factors   48
     
Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds   48
     
Item 3 – Defaults upon Senior Securities   48
     
Item 4 – Mine Safety Disclosures   48
     
Item 5 – Other Information   48
     
Item 6 – Exhibits   49
     
Exhibit Index   49
     
SIGNATURES   50

 

i

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Balance Sheets as of

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
   (unaudited)     
Current assets        
Cash and cash equivalents   779    615 
Fixed short term bank and escrow deposits – restricted   1,068    1,020 
Prepaid expenses and other   257    515 
Governmental receivables   173    18 
Other receivables   140    123 
Total current assets   2,417    2,291 
           
Unproved oil and gas properties, full cost method (see Note 4)   21,033    16,637 
           
Property and equipment at cost          
Drilling rig and related equipment, net of accumulated depreciation of $2,627 and $2,215 (see note 2I)   4,958    5,510 
Property and equipment, net of accumulated depreciation of $707 and $686   112    74 
    5,070    5,584 
           
Right of Use Lease Assets (see Note 5)   826    194 
           
Other assets          
Assets held for severance benefits   520    475 
Total other assets   520    475 
           
Total assets   29,866    25,181 
           
Liabilities and Stockholders’ Equity          
           
Current liabilities          
Accounts payable   827    777 
Insurance financing (see note 6D)   75    432 
Lease obligation – current (see Note 5)   145    167 
Asset retirement obligation   571    571 
Accrued liabilities   462    693 
Total current liabilities   2,080    2,640 
           
Long-term liabilities          
Lease obligation – non-current (see Note 5)   652    24 
Provision for severance pay   529    499 
Total long-term liabilities   1,181    523 
           
Total liabilities   3,261    3,163 
           
Commitments and contingencies (see Note 6)   
 
    
 
 
           
Stockholders’ equity          
Common stock, par value $.01; Authorized: 1,200,000,000 shares at September 30, 2024: Issued and outstanding: 880,562,128 and 640,002,580 shares at September 30, 2024 and December 31, 2023, respectively   8,806    6,400 
Additional paid-in capital   309,975    302,177 
Accumulated deficit   (292,176)   (286,559)
Total stockholders’ equity   26,605    22,018 
           
Total liabilities and stockholders’ equity   29,866    25,181 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

1

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Operations (Unaudited)

 

   For the three months ended   For the nine months ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
General and administrative   1,143    1,332    3,519    4,106 
Post impairment of unproved oil and gas properties   
-
    36    
-
    129 
Other   632    379    2,113    1,978 
Loss from operations   (1,775)   (1,747)   (5,632)   (6,213)
                     
Other income (expense), net                    
Foreign exchange income (loss)   (20)   2    11    (2)
Financial income (expenses), net   4    2    4    (1)
                     
Loss, before income taxes   (1,791)   (1,743)   (5,617)   (6,216)
Income taxes   
-
    
-
    
-
    
-
 
                     
Net loss   (1,791)   (1,743)   (5,617)   (6,216)
                     
Net loss per share of common stock                    
Basic and diluted (in US$)   (0.00)   (0.00)   (0.01)   (0.01)
                     
Weighted-average shares outstanding                    
Basic and diluted (in thousands)   843,211    578,497    752,241    551,551 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

2

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)

 

For the three and nine months ended September 30, 2024  

 

   Common Stock   Additional
paid-in
   Subscription   Accumulated     
   Shares   Amounts   Capital   Receivables   deficit   Total 
   thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2023   640,002    6,400    302,177        (286,559)   22,018 
Funds received from sale of DSPP units and shares and exercise of warrants   240,422    2,405    9,755            12,160 
Funds received from option exercises   138    1    8            9 
Costs associated with the issuance of shares           (2,299)           (2,299)
Value of options granted to employees, directors and others as non-cash compensation           334            334 
Net loss                   (5,617)   (5,617)
Balances as of September 30, 2024   880,562    8,806    309,975        (292,176)   26,605 

 

   Common Stock   Additional
paid-in
   Subscription   Accumulated     
   Shares   Amounts   Capital   Receivable   deficit   Total 
   thousands   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Balances as of June 30, 2024   818,874    8,189    308,319    (985)   (290,385)   25,138 
Funds received from sale of DSPP units and shares and exercise of warrants   61,646    617    2,090    985    
    3,692 
Funds received from option exercises   42    
        
    
    
 
Costs associated with the issuance of shares       
    (536)   
    
    (536)
Value of options granted to employees, directors and others as non-cash compensation       
    102    
    
    102 
Net loss       
    
    
    (1,791)   (1,791)
Balances as of September 30, 2024   880,562    8,806    309,975    
    (292,176)   26,605 

 

* Less than one thousand.

  

3

 

 

Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited)

 

For the three and nine months ended September 30, 2023

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   deficit   Total 
   thousands  

US$

thousands

  

US$

thousands

  

US$

thousands

  

US$

thousands

 
Balances as of December 31, 2022   524,231    5,242    296,460    (278,602)   23,100 
Funds received from sale of DSPP units and shares and exercise of warrants   78,173    782    4,186    
    4,968 
Funds received from option exercises   150    2    10    
    12 
Costs associated with the issuance of shares       
    (610)   
    (610)
Value of options granted to employees, directors and others as non-cash compensation       
    923    
    923 
Net loss       
    
    (6,216)   (6,216)
Balances as of September 30, 2023   602,554    6,026    300,969    (284,818)   22,177 

 

   Common Stock   Additional
paid-in
   Accumulated     
   Shares   Amounts   Capital   deficit   Total 
   thousands   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Balances as of June 30, 2023   560,449    5,604    299,321    (283,075)   21,850 
Funds received from sale of DSPP units and shares and exercise of warrants   42,105    422    1,820    
    2,242 
Funds received from option exercises       
    
    
    
 
Costs associated with the issuance of shares       
    (437)   
    (437)
Value of options granted to employees, directors and others as non-cash compensation       
    265    
    265 
Net loss       
    
    (1,743)   (1,743)
Balances as of September 30, 2023   602,554    6,026    300,969    (284,818)   22,177 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

4

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Statements of Cash Flows (Unaudited)

 

   For the
nine months ended
September 30,
 
   2024   2023 
   US$
thousands
   US$
thousands
 
   (Unaudited)   (Unaudited) 
Cash flows from operating activities        
Net loss   (5,617)   (6,216)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation   598    601 
Amortization of Right of Use Lease Assets   197    208 
Cost of options issued to employees, directors and others as non-cash compensation   334    923 
Post impairment of unproved oil and gas properties   
-
    129 
Loss on sale of property and equipment   63    
-
 
Change in assets and liabilities, net:          
Other deposits   
-
    483 
Prepaid expenses and other   258    367 
Governmental receivables   (155)   257 
Lease obligation – current and non-current   (223)   (215)
Other receivables   (17)   (13)
Severance payable, net   (15)   (2)
Accounts payable   (440)   (300)
Accrued liabilities   (85)   (131)
Net cash used in operating activities   (5,102)   (3,909)
           
Cash flows from investing activities          
Acquisition of property and equipment   (59)   
-
 
Proceeds from sale of property and equipment   35    
-
 
Acquisition of drilling rig and related equipment   (178)   
-
 
Investment in unproved oil and gas properties   (4,187)   (2,045)
Net cash used in investing activities   (4,389)   (2,045)
           
Cash flows from financing activities          
Proceeds from exercise of stock options   9    12 
Costs paid related to the issuance of new shares   (2,466)   (610)
Proceeds from issuance of stock and exercise of warrants   12,160    4,968 
Net cash provided by financing activities   9,703    4,370 
           
Net (decrease)/increase in cash, cash equivalents and restricted cash   212    (1,584)
Cash, cash equivalents and restricted cash – beginning of period   1,635    3,114 
Cash, cash equivalents and restricted cash – end of period   1,847    1,530 
           
Supplemental schedule of cash flow information          
           
Non-cash investing and financing activities:          
Unpaid investments in oil & gas properties   840    677 
Unpaid Costs associated with the issuance of shares   167    
-
 
Depreciation of oil and gas equipment   16    
-
 
Addition of right of use lease assets and lease obligations   829    252 

 

The accompanying notes are an integral part of the unaudited interim consolidated condensed financial statements.

 

5

 

 

Cash, cash equivalents and restricted cash, are comprised as follows:

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Cash and cash equivalents   779    615 
Restricted cash included in fixed long-term bank deposits   1,068    1,020 
    1,847    1,635 

 

6

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations 

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 24 years of oil & gas exploration in Israel. As of September 30, 2024, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

New Megiddo Valleys License 434 (“NMVL 434”) – Megiddo-Jezreel #1 Re-Entry (“MJ-01”)

 

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

  

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee officially accepted our work plan for the MJ-01 re-completion project. This acceptance allowed us to sign agreements and secure mobilization dates with our service providers to commence and complete the project.

 

7

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern (cont’d)

 

The initial phase of our recompletion project consisted of a category three inspection of the drilling rig, rigging down from MJ-02 and moving and rigging up over the MJ-01 well.

 

Stage two of the operation involved drilling out both the steel plugs along with 625 meters (about 2,050 feet) of cement plugs and re-conditioning the wellbore to allow unhindered access to the selected zones for testing.

 

After six years of inactivity in a well over three miles deep, the MJ-01 wellbore presents a challenging environment. The crew appears to have experienced elastic and partial collapse of the casing in some areas. This led to the bottom hole assembly (“BHA”) becoming stuck over 4,000 meters from surface. Attempts to overpull the BHA were unsuccessful, and the crew completed a backoff operation which left over 500 meters of the BHA remaining downhole. This is not an uncommon occurrence with oil and gas drilling operations, but we do need to recover the “fish” to resume operations. The crew was unsuccessful in retrieving the remaining BHA with the tools that were on location and will require specialized tools and techniques to recover the entire fish. The specialized tools we need are not in Israel, but have been sourced, but not approved for mobilization due to the active conflict in Israel.

 

Another delay arose out of the logistical challenges we face. The ongoing conflict in the region has impacted shipping routes, the timely arrival of necessary equipment, and created travel difficulties for our rig crews. Our operations require specialized rig crews who are not available in Israel.

 

An even further delay has been created by many of our rig crew members reaching the limit of their work visas. This requires us to reset visas, which is not a simple process, and it adds another layer of delay and complexity. Moreover, the recent changes to visa eligibility have further complicated the process, as Israel, in just the last few months, has changed their 90-day visa renewals from resetting at the end of the year to resetting after six months after expiration. We are working with the Ministry of Interior on this issue. As a side note, the crew had to enter Israel under 90 day visas and not six month or 12 month visas in order to comply with the labor law requirements in place at the time the operation commenced.

 

In light of the combination of downhole, logistical, and crew challenges, as well as holidays, and the one-year remembrance of October 7, we have temporarily paused active operations. This is a necessary step to ensure the safety of our personnel and to ensure proper engineering and tools are brought to location to avoid lengthy delays waiting for additional tools should any be required once the job resumes. We anticipate that once we have the necessary tools and renewed visas for our crews, we can resume operations in Q4 2024 or Q1 2025. This is, of course, subject to the realities of the present geopolitical environment. The conflict in Israel, while not directly impacting our operations on a daily basis, creates uncertainties that could affect our schedule at any time.

 

While our MJ-01 re-completion project has faced a multitude of hurdles, including an active conflict, downhole issues and logistical challenges, we continue to move forward each time a safe opportunity permits continuation of operations. However, we will only move forward in coordination with Israeli authorities. We are actively monitoring the port situation to import the items needed to complete the current work program. We remain optimistic about making significant progress in the coming months.

 

8

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 1 - Nature of Operations, Basis of Presentation and Going Concern (cont’d)

 

B. Basis of Presentation 

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the operating results for the year ending December 31, 2024 or for any other subsequent interim period.

 

C. Going Concern 

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be in doubt. The consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the nine months ended September 30, 2024, the Company incurred a net loss of approximately $5.6 million and had an accumulated deficit of approximately $292 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

 

9

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies

 

A. Net Loss per Share Data 

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 33,337,132 in stock options and 29,303,152 in warrants would be anti-dilutive.

 

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 27,096,250 in stock options and 30,242,620 in warrants would be anti-dilutive.

 

B. Use of Estimates 

 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases, accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, political instability and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

Similar uncertainties are posed by the Israel-Hamas war, as well as the Israel-Lebanon war. The duration of both wars and its impact on the region and world is not fully known at this point in time. As stated previously in this report, our operations are paused and our rig crew workers are safely out of Israel and at home.

  

Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment 

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

10

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three and nine months ended September 30, 2024, the Company did not record any post-impairment charges.

 

During the three and nine months ended September 30, 2023, the Company recorded post-impairment charges of $36,000 and $129,000, respectively.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $21,033,000 and $16,637,000 as of September 30, 2024 and December 31, 2023, respectively.

 

D. Fair Value Measurements 

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At September 30, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

 

11

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

E. Stock-Based Compensation 

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants 

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties 

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

Zion did not have any related party transactions for the periods covered in this report.

 

12

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 2 - Summary of Significant Accounting Policies (cont’d)

 

H. Recently Adopted Accounting Pronouncements   

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

 

I. Depreciation and Accounting for Drilling Rig and Related Equipment

 

On March 12, 2020, Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

Zion purchased rig spare parts totaling approximately $178,000 during the year 2024 in preparation for its MJ-01 re-entry project.

 

Zion sold some excess scrap drilling pipe and accessories for approximately $35,000 to a local Israeli party during the year 2024. This transaction triggered a reduction in Other Drilling Assets, an accumulated depreciation adjustment and a loss on the disposal.

 

See the table below for a reconciliation of the rig-related activity during the period ended September 30, 2024:

 

I-35 Drilling Rig & Associated Equipment:

 

   Nine-months ended September 30, 2024 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    178    
-
    178 
Asset Depreciation   (476)   
-
    (118)   (594)
Asset Disposals   
-
    
-
    (97)   (97)
Asset Disposals for Self-Consumption   
-
    (39)   
-
    (39)
September 30, 2024   4,115    747    96    4,958 

 

13

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

   As of December 31, 2023 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2022   5,225    619    437    6,281 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (634)   
-
    (117)   (751)
Asset Disposals for Self-Consumption   
-
    (11)   
-
    (11)
December 31, 2023   4,591    608    311    5,510 

 

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000 shares, effective June 7, 2023.

 

A. 2021 Omnibus Incentive Stock Option Plan 

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the nine months ended September 30, 2024, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to five senior officers and two staff members at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through January 4, 2034. The fair value of the options at the date of grant amounted to approximately $11,000.

 

  ii.

Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,800.

 

  iii.

Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $500.

 

During the nine months ended September 30, 2023, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000.

 

  ii. Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500.

 

14

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

  iii.

Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through June 8, 2033. The fair value of the options at the date of grant amounted to approximately $1,500.

 

  iv.

Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $600.

 

  v.

Options to purchase 895,000 shares of Common Stock to five staff members and one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $60,000

 

  vi.

Options to purchase 3,350,000 shares of Common Stock to four senior officers and nine staff members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $211,000, and was recognized during the years 2023 and 2024.

 

  vii.

Options to purchase 3,600,000 shares of Common Stock to nine board members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $227,000, and was recognized during the years 2023 and 2024.

 

  viii. Options to purchase 55,000 shares of Common Stock to three consultants at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $3,000, and was recognized during the years 2023 and 2024.

 

B. Stock Options 

 

The stock option transactions since January 1, 2024 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   210,000    0.07 
Expired/Cancelled/Forfeited   (825,943)   1.72 
Exercised   (138,175)   0.07 
Outstanding, September 30, 2024   33,337,132    0.19 
Exercisable, September 30, 2024   33,337,132    0.19 

 

15

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The following table summarizes information about stock options outstanding as of September 30, 2024:

 

Shares underlying outstanding options (non-vested)     Shares underlying outstanding options (fully vested)  
Range of
exercise
price
    Number
outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
    Range of
exercise
price
    Number
Outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
 
US$                 US$     US$                 US$  
                          0.01       107,500       2.25       0.01  
                          0.01       50,000       2.26       0.01  
                          0.01       60,000       2.55       0.01  
                          0.01       200,000       3.64       0.01  
                          0.01       40,000       3.00       0.01  
                          0.01       70,000       3.25       0.01  
                          0.01       25,000       3.26       0.01  
                          0.01       30,000       3.41       0.01  
                          0.01       4,000       3.52       0.01  
                          0.01       25,000       4.27       0.01  
                          0.01       35,000       5.97       0.01  
                          0.01       150,000       5.14       0.01  
                          0.01       35,000       4.97       0.01  
                          0.01       75,000       6.27       0.01  
                          0.01       200,000       6.64       0.01  
                          0.01       300,000       6.80       0.01  
                          0.01       10,000       6.92       0.01  
                          0.01       500,000       7.27       0.01  
                          0.01       55,000       7.30       0.01  
                          0.01       960,000       7.55       0.01  
                          0.01       75,000       7.87       0.01  
                          0.01       10,000       7.93       0.01  
                          0.01       795,000       7.99       0.01  
                          0.01       25,000       8.27       0.01  
                          0.01       10,000       8.93       0.01  
                          0.01       895,000       8.98       0.01  
                          0.01       25,000       9.27       0.01  
                          0.01       10,000       9.93       0.01  
                          0.06       50,000       8.27       0.06  
                          0.07       125,000       9.27       0.07  
                          0.07       6,980,000       8.99       0.07  
                          0.14       210,000       7.30       0.14  
                          0.15       3,200,000       7.27       0.15  
                          0.15       6,354,325       7.55       0.15  
                          0.16       340,000       1.19       0.16  
                          0.16       75,000       5.20       0.16  
                          0.18       25,000       1.17       0.18  
                          0.18       5,130,000       7.99       0.18  
                          0.24       25,000       7.84       0.24  
                          0.24       118,000       7.87       0.24  
                          0.25       50,000       6.92       0.25  
                          0.25       363,000       6.92       0.25  
                          0.28       25,000       0.93       0.28  
                          0.28       25,000       4.93       0.28  
                          0.29       25,000       2.71       0.29  
                          0.39       1,435,000       6.78       0.39  
                          0.59       1,400,000       2.64       0.59  
                          0.59       1,600,000       6.64       0.59  
                          0.92       350,000       2.26       0.92  
                          0.92       550,000       6.27       0.92  
                          1.38       105,307       0.26       1.38  
                              0.01-1.38       33,337,132               0.19  

 

16

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Granted to employees  

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.07 
Dividend yields   
    
 
Expected volatility   133%-134%   135%-137%
Risk-free interest rates   3.71%-3.97%   3.85%-4.61%
Expected lives (in years)   5.00    5.00-5.50 
Weighted-average grant date fair value  $0.07   $0.06 

 

Granted to non-employees

 

The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date   
   $0.07 
Dividend yields   
    
 
Expected volatility   
    134%
Risk-free interest rates   
    4.1%
Expected lives (in years)   
    10 
Weighted-average grant date fair value   
   $0.05 

 

17

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

C. Compensation Cost for Warrant and Option Issuances   

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  101       264  

 

 For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  331       921  

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  1        

 

For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  3       2  

 

18

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

D. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 2, 2023, any outstanding ZNWAD warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 1, 2023, any outstanding ZNWAE warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 14, 2023, any outstanding ZNWAF warrants expired.

 

On December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January 8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of January 8, 2024, any outstanding ZNWAG warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of April 2, 2023, any outstanding ZNWAH warrants expired.

 

19

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 29, 2023, any outstanding ZNWAJ warrants expired.

  

On September 15, 2020, the Company extended the termination date of the ZNWAK warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of February 25, 2023, any outstanding ZNWAK warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 26, 2023, any outstanding ZNWAL warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAM warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

20

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On March 28, 2024, the Company extended the termination date of the ZNWAM warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The ZNWAN warrants became exercisable on May 16, 2021 and continued to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

 

As of May 16, 2023, any outstanding ZNWAN warrants expired.

 

The ZNWAO warrants became exercisable on June 12, 2021 and continued to be exercisable through June 12, 2023 at a per share exercise price of $.25.

 

As of June 12, 2023, any outstanding ZNWAO warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of a Unit (shares of stock and warrants) to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable through July 15, 2023 at a revised per share exercise price of $.05.

 

Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. 

 

21

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continued to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 during 2021 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAT.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAU.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed two additional Waiver Term Sheets with a participant consisting of shares of stock. After conclusion of the program on December 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the year ended December 31, 2023, Zion incurred $1,120,000 in equity issuance costs.

 

On January 1, 2024, the Company executed a Waiver Term Sheet with a participant consisting of shares of stock. After conclusion of the program on March 31, 2024, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

During the three and nine months ended September 30, 2024, Zion incurred $536,000 and $2,299,000 in equity issuance costs. During the three and nine months ended September 30, 2023, Zion incurred $437,000 and $610,000 in equity issuance costs. 

 

On April 1, 2024, the Company executed its current Waiver Term Sheet with a participant consisting of shares of stock and warrants. On or around September 30, 2024, a second amendment to this latest Waiver Term Sheet was signed with the participant. The program terminates at the earlier of: (a) a maximum purchase of $10,000,000 through the DSPP, (b) December 31, 2024 or (c) the closing price of Zion’s stock is 15 cents per share for five (5) consecutive days. Additional terms of the Waiver Term Sheet include the pro-rata issuance of up to 10,000,000 warrants with an exercise price of $.25 per share and an expiration date of April 1, 2025, in the event the Participant purchases up to $10,000,000 of the Company’s stock by December 31, 2024.

 

22

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

During 2024, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 65% of the net cash raised through the DSPP. 

 

During 2023, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 54% of the net cash raised through the DSPP.

 

On March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December 15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock Purchase Plan. The Prospectus forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15, 2021.

 

Amendment No. 2 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13, 2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche began on April 10, 2023 and terminated on April 27, 2023.

 

The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX” under the third tranche.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.

 

The ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price of $0.05.

 

As of June 28, 2023, any outstanding ZNWAV warrants expired.

 

The ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price of $0.05.

 

As of July 13, 2023, any outstanding ZNWAW warrants expired.

 

The ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price of $0.05.

 

23

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

On July 31, 2023, any outstanding ZNWAX warrants expired.

 

The ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise price of $0.05.

 

On September 10, 2023, any outstanding ZNWAY warrants expired.

 

Amendment No. 3 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.

 

Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May 15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWAZ warrants became exercisable on July 17, 2023 and continued to be exercisable through July 17, 2024 at a per share exercise price of $0.25.

 

On July 17, 2024, any outstanding ZNWAZ warranted expired.

 

Amendment No. 4 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and was scheduled to terminate on December 31, 2023. See Amendment No. 5 below for data on an extension.

 

Our Unit Program consists of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 4 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option began on November 6, 2023 and terminated on December 31, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWBA.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWBA warrants became exercisable on January 15, 2024, and continue to be exercisable through January 15, 2025, unless extended, at a per share exercise price of $0.25. See Amendment No. 5 below for new dates.

 

24

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Amendment No. 5 – Extension of Termination Date to January 31, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consisted of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate December 31, 2023, but now was scheduled to terminate on January 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on February 15, 2024, instead of January 15, 2024, and continue to be exercisable through February 15, 2025, instead of January 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.

 

The date of this Amendment No. 5 to Prospectus Supplement was December 20, 2023.

 

Amendment No. 6 – Extension of Termination Date to February 29, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate January 31, 2024, but now was scheduled to terminate February 29, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on March 15, 2024, instead of February 15, 2024, and continue to be exercisable through March 15, 2025, instead of February 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 6 to Prospectus Supplement was January 29, 2024.

  

25

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Amendment No. 7 – Extension of Termination Date to March 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate February 29, 2024, but now will terminate March 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on April 15, 2024, instead of March 15, 2024, and continue to be exercisable through April 15, 2025, instead of March 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 7 to Prospectus Supplement was February 26, 2024.

 

Amendment No. 8 – Extension of Termination Date to April 30, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate March 31, 2024, but now will terminate April 30, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on May 15, 2024, instead of April 15, 2024, and continue to be exercisable through May 15, 2025, instead of April 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

26

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 8 to Prospectus Supplement was March 23, 2024.

 

Amendment No. 9 – Extension of Termination Date to May 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate April 30, 2024, but now will terminate May 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on June 15, 2024, instead of May 15, 2024, and continue to be exercisable through June 15, 2025, instead of May 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 9 to Prospectus Supplement was April 24, 2024.

 

Amendment No. 10 – Extension of Termination Date to August 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate May 31, 2024, but now will terminate August 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

27

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The ZNWBA warrants will be first exercisable on September 15, 2024, instead of June 15, 2024, and continue to be exercisable through September 14, 2025, instead of June 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 10 to Prospectus Supplement was May 29, 2024.

 

Amendment No. 11 – Extension of Termination Date to October 15, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate August 31, 2024, but now will terminate October 15, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on November 15, 2024, instead of September 15, 2024, and continue to be exercisable through November 14, 2025, instead of September 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

28

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The date of this Amendment No. 11 to Prospectus Supplement was August 22, 2024.

 

Amendment No. 12 – Extension of Termination Date to December 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate October 15, 2024, but now will terminate December 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on January 31, 2025, instead of November 15, 2024, and continue to be exercisable through January 31, 2026, instead of November 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 12 to Prospectus Supplement was October 9, 2024.

 

For the three and nine months ended September 30, 2024, approximately $3,692,000 and $12,160,000 were raised under the DSPP program, respectively. The $3,692,000 and $12,160,000 figures were reduced by $536,000 and $2,299,000, respectively, in equity issuance costs to an outside party resulting in net cash provided of $3,156,000 and $9,861,000, respectively.

 

For the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program, respectively. The $1,805,000 and $4,358,000 figures are net of $437,000 and $610,000 in equity issuance costs to an outside party, respectively.

 

The company raised approximately $1,319,000 from the period October 1, 2024 through November 6, 2024, under the DSPP program.

 

29

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQB market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification and accounting purposes only.

 

E. Subscription Rights Offering   

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of June 29, 2023, any outstanding ZNWAI warrants expired.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

F. Warrant Table  

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
09/30/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
      -
    
       -
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    (153,800)   
-
 
Outstanding warrants           29,697,020    
-
    
-
    (393,868)   29,303,152 

 

30

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 3 - Stockholders’ Equity (cont’d)

 

G. Warrant Descriptions of Current Warrants

 

The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with a future expiration date.

 

      Period of Grant   US$   Expiration Date
ZNWAA Warrants  A,B,E,H   March 2013 – December 2014    2.00   January 31, 2025
ZNWAM Warrants  C,F,I,J   January 2021 – March 2021    0.05   December 31, 2024
ZNWAQ Warrants  C,F,I,J   June 2021    0.05   December 31, 2024
ZNWAS Warrants  D   August 2021 – March 2022    0.25   December 31, 2025
ZNWAT Warrants  D   August – September 2022    0.25   December 31, 2025
ZNWAU Warrants  D   October – November 2022    0.25   December 31, 2025
ZNWBA Warrants  G,K   November – December 2024    0.25   January 31, 2026

 

A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.

 

H On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.

 

I On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.

 

J On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
   
K

On May 29, 2024, the Company filed Amendment No. 10 whereby the current unit option was extended to August 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On August 22, 2024, the Company filed Amendment No. 11 whereby the current unit option was extended to October 15, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended.  On October 9, 2024, the Company filed Amendment No. 12 whereby the current unit option was extended to December 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended to January 31, 2026.

 

31

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 4 - Unproved Oil and Gas Properties, Full Cost Method

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   6,050    2,538 
Capitalized salary costs   2,521    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,005    10,198 
Other costs   39    39 
    21,033    16,637 

 

Post Impairment of unproved oil and gas properties comprised as follows:

 

   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   
     -
    20    
     -
    76 
Capitalized salary costs   
-
    
-
    
-
    
-
 
Capitalized interest costs   
-
    
-
    
-
    
-
 
Legal costs, license fees and other preparation costs   
-
    16    
-
    53 
Other costs   
-
    
-
    
-
    
-
 
    
-
    36    
-
    129 

 

Changes in Unproved oil and gas properties during the three and nine months ended September 30, 2024 and 2023 are as follows:

 

   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   2,865    58    3,512    204 
Capitalized salary costs   26    25    77    77 
Capitalized interest costs   
-
    
-
    -    - 
Legal and seismic costs, license fees and other preparation costs   327    103    807    301 
Other costs   
-
    
-
    -    - 
Impairment of unproved oil and gas properties   
-
    (36)   -    (129)
    *3,218    *150    *4,396    *453 

  

* Inclusive of non-cash amounts of approximately $146,000, and $129,000 during the three months ended September 30, 2024, and 2023, respectively
   
* Inclusive of non-cash amounts of approximately $856,000, and $677,000 during the nine months ended September 30, 2024, and 2023, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

 

32

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use lease assets and lease obligations  

 

The Company is a lessee in several non-cancellable operating leases for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheet as of September 30, 2024 and December 31, 2023:

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $826   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $145   $167 
Non-current operating lease liabilities  $652   $24 
Total operating lease liabilities  $797   $191 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s field office in Caesarea, Israel is under lease for 6,566 square feet.

 

The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,500) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of September 30, 2024 are:

 

   September 30,
2024
 
Weighted average remaining lease term (years)   5.9 
Weighted average discount rate   7.8%

 

33

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 5 - Right of use lease assets and leases obligations (cont’d)

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of September 30, 2024:

 

    US$
thousands
 
2024    49 
2025    155 
2026    151 
2027    149 
2028    149 
Thereafter    346 
Total undiscounted future minimum lease payments    999 
Less: portion representing imputed interest    (202)
Total undiscounted future minimum lease payments    797 

 

Operating lease costs were $75,000 and $224,000 for the three and nine months ended September 30, 2024, respectively.

 

Operating lease costs were $76,000 and $203,000 for the three and nine months ended September 30, 2023, respectively. Operating lease costs are included within general and administrative expenses on the statements of operations.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $55,000 and $223,000 for the three and nine months ended September 30, 2024, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $76,000 and $203,000 for the three and nine months ended September 30, 2023, respectively These amounts are included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $nil and $829,000 for the three and nine months ended September 30, 2024, respectively.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $252,000 and $252,000 for the three and nine months ended September 30, 2023, respectively.

 

34

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies

 

A. Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

B. Market Conditions – Coronavirus, Israel-Hamas War, the Israel-Hezbollah War and Russia-Ukraine War

 

Coronavirus

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

Israel-Hamas War

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

Israel-Hezbollah War and Wider Hostilities

 

Immediately after the October 7, 2023 Hamas attack on Israel, the terrorist organization Hezbollah (in Lebanon) began launching daily rockets into Israel. Over the course of the next several months, both Hezbollah and Israel traded rocket fire into the other country, but without engaging in a full war. During Q3 2024, both sides increased the frequency and number of missiles fired. In September 2024, Israel began a ground invasion into Lebanon and both sides are at war today. As a result of the wars in Israel, most airlines are not flying in and out of Israel, and the ports in Haifa and Ashdod remain closed.

 

Russia-Ukraine War

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the quarter ended September 30, 2024, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company and actions that may be taken by governmental authorities related to the war.

 

C. Environmental and Onshore Licensing Regulatory Matters   

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings. 

 

35

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies (cont’d)

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of September 30, 2024, and December 31, 2023, the Company accrued $nil and $nil for license regulatory matters.

 

D. Insurance Financing

 

Effective November 16, 2023, the Company renewed its third-party liability (“TPL”) insurance policy in Israel with total premiums, taxes and fees for $76,263. A cash down payment of $22,699 was paid on November 16, 2023. Under the terms of the insurance financing, payments of $5,356, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on December 16, 2023. The Company has completed its financing commitment pertaining to the TPL insurance as of September 30, 2024.

 

Effective December 28, 2023, the Company renewed its D&O insurance policy with total premiums, taxes and fees for $441,598. A cash down payment of $68,733 was paid on December 13, 2023. Under the terms of the insurance financing, payments of $37,287, which include interest at the rate of 13.4% per annum, are due each month for 10 months commencing on January 28, 2024.

 

Effective March 12, 2024, 2024, the Company renewed its rig insurance policy with total premiums, taxes and fees for $94,989. A cash down payment of $37,637 was paid on February 23, 2024. Under the terms of the insurance financing, payments of $9,499, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on April 12, 2024.

 

As of September 30, 2024 and December 31, 2023, the Company had contractual obligations to pay for various lines of insurance, including directors and officers, rig and third-party liability. The balances for insurance financing were $75,000 and $432,000, respectively.

 

We haven’t experienced any resistance from our insurance carriers as a result of the Israel-Hamas war or Israel-Hezbollah war, but we acknowledge the uncertainties that the war(s) creates in that respect. 

 

E. Bank Guarantees

 

As of September 30, 2024, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $971,000) and others (approximately $91,000) with respect to its drilling operation in an aggregate amount of approximately $1,062,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

F. Vendor Concentration

 

The Company’s financial instruments that are exposed to a concentration of credit risk are accounts payable. At September 30, 2024, there were two suppliers that represent 10% or more of the Company’s accounts payable balance. At December 31, 2023, there were three suppliers that represent 10% or more of the Company’s accounts payable balance.

 

36

 

 

Zion Oil & Gas, Inc.

 

Consolidated Condensed Notes to Financial Statements (Unaudited)

 

Note 6 - Commitments and Contingencies (cont’d)

 

G. Risks

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through September 30, 2024, the USD has fluctuated by approximately 2.3% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At September 30, 2024, we had cash, cash equivalents and short-term bank deposits of approximately $1,847,000. The weighted average annual interest rate related to our cash and cash equivalents for the three and nine months ended September 30, 2024, exclusive of funds at US banks that earn no interest, was approximately 2.8% and 2.9%, respectively.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

Note 7 - Subsequent Events

 

The Company has evaluated subsequent events through November 7, 2024, the date of filing of this Quarterly Report on Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements, other than the following:

 

(i) Approximately $1,319,000 was collected through the Company’s DSPP program during the period October 1 through November 6, 2024.

 

37

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH OUR UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND THE RELATED NOTES TO THOSE STATEMENTS INCLUDED IN THIS FORM 10-Q. SOME OF OUR DISCUSSION IS FORWARD-LOOKING AND INVOLVES RISKS AND UNCERTAINTIES. FOR INFORMATION REGARDING RISK FACTORS THAT COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS, REFER TO THE DISCUSSION OF RISK FACTORS IN THE “DESCRIPTION OF BUSINESS” SECTION OF OUR ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2023, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

 

Forward-Looking Statements

 

Certain statements made in this discussion are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may materially differ from actual results.

 

Forward-looking statements can be identified by terminology such as “may”, “should”, “expects”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, or “continue” or the negative of these terms or other comparable terminology and include, without limitation, statements regarding:

 

  the Israel-Hamas war which began in October 2023 and its effect on our exploration program;

 

the Israel-Hezbollah war which began in 2024, along with wider regional hostilities towards Israel, and its effect on our exploration program;

 

  the going concern qualification in our consolidated condensed financial statements;

 

  our ability to obtain new license areas to continue our exploration program;

 

  our liquidity and our ability to raise capital to finance our overall exploration and development activities within our license area;

 

  our ability to continue meeting the requisite continued listing requirements by OTCQB;

 

  interruptions, increased financial costs and other adverse impacts of the covid 19 coronavirus pandemic, the Israel-Hamas war, the Israel-Hezbollah war and the Russia-Ukraine war on the drilling and testing of our petroleum exploration program and our capital raising efforts;

 

  our ability to explore for and develop natural gas and oil resources successfully and economically within a license area;

 

  our ability to maintain the exploration license rights to continue our petroleum exploration program;

 

  the availability of equipment, such as seismic equipment, drilling rigs, and production equipment as well as access to qualified personnel;

 

  the impact of governmental regulations, permitting and other legal requirements in Israel relating to onshore exploratory drilling;

 

  our estimates of the time frame within which future exploratory activities will be undertaken;

 

  changes in our exploration plans and related budgets;

 

  the quality of future license areas with regard to, among other things, the existence of reserves in economic quantities;

 

  anticipated trends in our business;

 

  our future results of operations;

 

  our capital expenditure program;

 

  future market conditions in the oil and gas industry

 

  the demand for oil and natural gas, both locally in Israel and globally; and

 

  the impact of fluctuating oil and gas prices on our exploration efforts

 

38

 

  

All references in this Quarterly Report to the “Company”, “Zion”, “we”, “us”, or “our”, are to Zion Oil and Gas, Inc., a Delaware corporation, and its wholly-owned subsidiaries, Zion Drilling, Inc. and Zion Drilling Services, Inc. described below.

 

Current Exploration and Operation Efforts

 

Zion Oil and Gas, Inc., a Delaware corporation, is an oil and gas exploration company with a history of 24 years of oil and gas exploration in Israel. We were incorporated in Florida on April 6, 2000 and reincorporated in Delaware on July 9, 2003. We completed our initial public offering in January 2007. Our common stock, par value $0.01 per share (the “Common Stock”) currently trades on the OTCQB marketplace of OTC Markets, Inc. under the symbol “ZNOG” and our Common Stock warrant under the symbol “ZNOGW.” On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

 

We continue our exploration focus here based on our studies as it appears to possess the key geologic ingredients of an active petroleum system with significant exploration potential. As previously announced, Zion is deploying new technologies and stimulation methods for its current re-entry into the MJ-01 well with the objective of potentially unlocking hydrocarbon flows in several identified key zones.

 

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee officially accepted our work plan for the MJ-01 re-completion project. This acceptance allowed us to sign agreements and secure mobilization dates with our service providers to commence and complete the project.

 

The initial phase of our recompletion project consisted of a category three inspection of the drilling rig, rigging down from MJ-02 and moving and rigging up over the MJ-01 well.

 

Stage two of the operation involved drilling out both the steel plugs along with 625 meters (about 2,050 feet) of cement plugs and re-conditioning the wellbore to allow unhindered access to the selected zones for testing.

 

After six years of inactivity in a well over three miles deep, the MJ-01 wellbore presents a challenging environment. The crew appears to have experienced elastic and partial collapse of the casing in some areas. This led to the bottom hole assembly (“BHA”) becoming stuck over 4,000 meters from surface. Attempts to overpull the BHA were unsuccessful, and the crew completed a backoff operation which left over 500 meters of the BHA remaining downhole. This is not an uncommon occurrence with oil and gas drilling operations, but we do need to recover the fish to resume operations. The crew was unsuccessful in retrieving the remaining BHA with the tools that were on location and will require specialized tools and techniques to recover the entire fish. The specialized tools we need are not in Israel, but have been sourced, but not approved for mobilization due to the active conflict in Israel.

 

Another delay arose out of the logistical challenges we face. The ongoing conflict in the region has impacted shipping routes, the timely arrival of necessary equipment, and created travel difficulties for our rig crews. Our operations require specialized rig crews who are not available in Israel.

 

An even further delay has been created by many of our rig crew members reaching the limit of their work visas. This requires us to reset visas, which is not a simple process, and it adds another layer of delay and complexity. Moreover, the recent changes to visa eligibility have further complicated the process, as Israel, in just the last few months, has changed their 90-day visa renewals from resetting at the end of the year to resetting after six months after expiration. We are working with the Ministry of Interior on this issue. As a side note, the crew had to enter Israel under 90 day visas and not six month or 12 month visas in order to comply with the labor law requirements in place at the time the operation commenced.

 

39

 

 

In light of the combination of downhole, logistical, and crew challenges, as well as holidays, and the one-year remembrance of October 7, we have temporarily paused active operations. This is a necessary step to ensure the safety of our personnel and to ensure proper engineering and tools are brought to location to avoid lengthy delays waiting for additional tools should any be required once the job resumes. We anticipate that once we have the necessary tools and renewed visas for our crews, we can resume operations in Q4 2024 or Q1 2025. This is, of course, subject to the realities of the present geopolitical environment. The conflict in Israel, while not directly impacting our operations on a daily basis, creates uncertainties that could affect our schedule at any time.

  

While our MJ-01 re-completion project has faced a multitude of hurdles, including an active conflict, downhole issues and logistical challenges, we continue to move forward each time a safe opportunity permits continuation of operations. However, we will only move forward in coordination with Israeli authorities. We are actively monitoring the port situation to import the items needed to complete the current work program. We remain optimistic about making significant progress in the coming months.

  

I-35 Drilling Rig & Associated Equipment

 

   Nine-month period ended September 30, 2024 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   -    178    -    178 
Asset Depreciation   (476)   -    (118)   (594)
Asset Disposals   -    -    (97)   (97)
Asset Disposals for Self-Consumption   -    (39)   -    (39)
September 30, 2024   4,115    747    96    4,958 

 

   As of December 31, 2023 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2022   5,225    619    437    6,281 
Asset Additions   -    -    -    - 
Asset Depreciation   (634)   -    (117)   (751)
Asset Disposals for Self-Consumption   -    (11)   -    (11)
December 31, 2023   4,591    608    311    5,510 

 

Zion’s ability to fully undertake all of these aforementioned activities is subject to its raising the needed capital from its continuing offerings, of which no assurance can be provided.

 

40

 

  

 

Map 1. Zion’s New Megiddo License 428 as of September 30, 2024.

 

41

 

 

Onshore Licensing, Oil and Gas Exploration and Environmental Guidelines

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental cleanup of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner, the Energy Ministry, and the Environmental Ministry in recent years as it pertains to oil and gas activities. Mention of these guidelines was included in previous Zion Oil & Gas filings.

 

We acknowledge that these new regulations are likely to increase the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that additional financial burdens could occur as a result of the Ministry requiring cash reserves that could otherwise be used for operational purposes.

 

Capital Resources Highlights

 

We need to raise significant funds to finance the continued exploration efforts and maintain orderly operations. To date, we have funded our operations through the issuance of our securities and convertible debt. We will need to continue to raise funds through the issuance of equity and/or debt securities (or securities convertible into or exchangeable for equity securities). No assurance can be provided that we will be successful in raising the needed capital on terms favorable to us (or at all).

 

The Dividend Reinvestment and Stock Purchase Plan

 

On March 13, 2014, Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On March 27, 2014, we launched our Dividend Reinvestment and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders and interested investors can purchase shares of the Company’s Common Stock as well as units of the Company’s securities directly from the Company. The terms of the DSPP are described in the Prospectus Supplement originally filed on March 31, 2014 (the “Original Prospectus Supplement”) with the Securities and Exchange Commission (“SEC”) under the Company’s effective registration Statement on Form S-3, as thereafter amended.

 

Please see Footnote 3D (“Dividend Reinvestment and Stock Purchase Plan (“DSPP”)), which is a part of this Form 10-Q filing, for details about specific stock purchase and unit programs, dates, and filings during the years 2023 and 2024.

 

For the three and nine months ended September 30, 2024, approximately $3,692,000 and $12,160,000 were raised under the DSPP program, respectively. The $3,692,000 and $12,160,000 figures were reduced by $536,000 and $2,299,000, respectively, in equity issuance costs to an outside party resulting in net cash provided of $3,156,000 and $9,861,000, respectively.

 

For the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program, respectively. The $4,358,000 figure is net of $610,000 in equity issuance costs to an outside party.

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
09/30/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    -    -    -    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    -    -    (240,068)   - 
ZNWAM  $0.05   12/31/2024   4,376,000    -    -    -    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    -    -    -    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800    -    -    (153,800)   - 
Outstanding warrants           29,697,020    -    -    (393,868)   29,303,152 

 

42

 

 

Principal Components of our Cost Structure

 

Our operating and other expenses primarily consist of the following:

 

  Impairment of Unproved Oil and Gas Properties: Impairment expense is recognized if a determination is made that a well will not be commercially productive. The amounts include amounts paid in respect of the drilling operations as well as geological and geophysical costs and various amounts that were paid to Israeli regulatory authorities.

 

  General and Administrative Expenses: Overhead, including payroll and benefits for our corporate staff, costs of managing our exploratory operations, audit and other professional fees, and legal compliance is included in general and administrative expenses. General and administrative expenses also include non-cash stock-based compensation expense, investor relations related expenses, lease and insurance and related expenses.

 

  Depreciation, Depletion, Amortization and Accretion: The systematic expensing of the capital costs incurred to explore for natural gas and oil represents a principal component of our cost structure. As a full cost company, we capitalize all costs associated with our exploration, and apportion these costs to each unit of production, if any, through depreciation, depletion and amortization expense. As we have yet to have production, the costs of abandoned wells are written off immediately versus being included in this amortization pool.

 

Going Concern Basis

 

Since we have limited capital resources, no revenue to date and a loss from operations, our consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. The appropriateness of using the going concern basis is dependent upon our ability to obtain additional financing or equity capital and, ultimately, to achieve profitable operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Israel-Hamas War

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

Israel-Hezbollah War and Wider Hostilities Towards Israel

 

Immediately after the October 7, 2023 Hamas attack on Israel, the terrorist organization Hezbollah in Lebanon began launching daily rockets into Israel. Over the course of the next several months, both Hezbollah and Israel traded rocket fire into the other country, but without engaging in a full war. During Q3 2024, both sides increased the frequency and number of missiles fired. In September 2024, Israel began a ground invasion into Lebanon and both sides are war today. As a result of the wars in Israel, most airlines are not flying in and out of Israel, and the ports in Haifa and Ashdod remain closed.

 

Russia – Ukraine War

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the year ended December 31, 2023, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company and actions that may be taken by governmental authorities related to the war.

 

Critical Accounting Policies

 

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated condensed financial statements and the reported amounts of revenues and expense during the reporting period.

 

We have identified the accounting principles which we believe are most critical to the reported financial status by considering accounting policies that involve the most complex of subjective decisions or assessment.

 

43

 

 

Impairment of Oil and Gas Properties

 

We follow the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in income from continuing operations before income taxes, and the adjusted carrying amount of the unproved properties is amortized on the unit-of-production method.

 

Our oil and gas properties represent an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. A further impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

Abandonment of properties is accounted for as adjustments to capitalized costs. The net capitalized costs are subject to a “ceiling test” which limits such costs to the aggregate of the estimated present value of future net revenues from proved reserves discounted at ten percent based on current economic and operating conditions, plus the lower of cost or fair market value of unproved properties. The recoverability of amounts capitalized for oil and gas properties is dependent upon the identification of economically recoverable reserves, together with obtaining the necessary financing to exploit such reserves and the achievement of profitable operations.

 

During the three months ended September 30, 2024, and 2023, respectively, the Company recorded $nil and $36,000 in post-impairment charges.

 

During the nine months ended September 30, 2024, and 2023, respectively, the Company recorded $nil and $129,000 post-impairment charges.

 

The total net book value of our unproved oil and gas properties under the full cost method is $21,033,000 and $16,637,000 at September 30, 2024 and at December 31, 2023, respectively.

 

Asset Retirement Obligation

 

We record a liability for asset retirement obligation at fair value in the period in which it is incurred and a corresponding increase in the carrying amount of the related long-lived assets.

 

Fair Value Considerations

 

We follow ASC 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

There are three levels of inputs to fair value measurements - Level 1, meaning the use of quoted prices for identical instruments in active markets; Level 2, meaning the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; and Level 3, meaning the use of unobservable inputs. We use Level 1 inputs for fair value measurements whenever there is an active market, with actual quotes, market prices, and observable inputs on the measurement date. We use Level 2 inputs for fair value measurements whenever there are quoted prices for similar securities in an active market or quoted prices for identical securities in an inactive market. We use observable market data whenever available.

 

44

 

 

RESULTS OF OPERATIONS

 

   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   (US $ in thousands)   (US $ in thousands) 
Operating costs and expenses:                
General and administrative expenses   1,143    1,332    3,519    4,106 
Other   632    379    2,113    1,978 
Impairment of unproved oil and gas properties   -    36    -    129 
Subtotal Operating costs and expenses   1,775    1,747    5,632    6,213 
                     
Other expense (income), net   16    (4)   (15)   3 
                     
Net loss   1,791    1,743    5,617    6,216 

 

Revenue. We currently have no revenue generating operations.

 

Operating costs and expenses. Operating costs and expenses for the three and nine months ended September 30, 2024 were $1,775,000 and $5,632,000, respectively, compared to $1,747,000 and $6,213,000, respectively, for the three and nine months ended September 30, 2023. Operating costs and expenses for the three months ended September 30, 2024 were $28,000 (1.6%) higher compared to the three months ended September 30, 2023. Operating costs for the nine months ended September 30, 2024 were $581,000 (9.4%) lower compared to the nine months ended September 30, 2023.

 

General and administrative expenses. General and administrative expenses (“G&A expenses”) for the three and nine months ended September 30, 2024 were $1,143,000 and $3,519,000, respectively, compared to $1,332,000 and $4,106,000, respectively, for the three and nine months ended September 30, 2023. This expense grouping includes salaries, benefits, stock option expenses and professional fees. G&A expenses were lower by $189,000, or 14.2%, during the most recent quarter versus the prior year primarily due to lower salaries expenses and expenses associated with stock option grants. G&A expenses were lower by $587,000, or 14.3%, during the first nine months of 2024 as compared to the nine months of 2023, primarily due to lower expenses associated with stock option grants.

 

Other expense. Other expenses during the three and nine months ended September 30, 2024 were $632,000 and $2,113,000, respectively, compared to $379,000 and $1,978,000, respectively, for the three and nine months ended September 30, 2023. Other general and administrative expenses are comprised of non-compensation and non-professional expenses incurred. Other expenses increased by $253,000, or about 66.8%, and by $135,000, or about 6.8%, for the three and nine months ended September 30, 2024, respectively. Zion incurred lower annual meeting and insurance premium expenses, but this was partially offset by higher marketing and investor relations expenses.

 

Impairment of unproved oil and gas properties. Impairment of unproved oil and gas properties expenses during the three and nine months ended September 30, 2024 were $nil and $nil compared to $36,000 and $129,000 for the three and nine months ended September 30, 2023. The expenses recorded in 2023 are post impairment charges to the impairment recorded during 2023 related to the MJ-2 well.

 

Other expense (income), net. Other expenses (income) during the three and nine months ended September 30, 2024 were $16,000 and ($15,000), respectively, compared to ($4,000) and $3,000, respectively, for the three and nine months ended September 30, 2023. The expenses in this category are comprised of foreign currency exchange costs, primarily the New Israeli Shekel (NIS) to the US dollar, and the financial expenses/income.

 

Net Loss. Net loss for the three and nine months ended September 30, 2024 were $1,791,000 and $5,617,000 compared to $1,743,000 and $6,216,000 for the three and nine months ended September 30, 2023.

 

Liquidity and Capital Resources

 

Liquidity is a measure of a company’s ability to meet potential cash requirements. As discussed above, we have historically met our capital requirements through the issuance of common stock as well as proceeds from the exercise of warrants and options to purchase common shares. As disclosed on our Balance Sheet, the company has 1,200,000,000 shares of authorized common stock and 880,562,128 shares issued as of September 30, 2024. We are considering increasing our authorized shares during the next proxy season in 2025.

 

Our ability to continue as a going concern is dependent upon obtaining the necessary financing to complete further exploration and development activities and generate profitable operations from our oil and natural gas interests in the future. Our current operations are dependent upon the adequacy of our current assets to meet our current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, our ability to continue as a going concern will be impaired. Our financial statements for the nine months ended September 30, 2024 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. We have incurred a history of operating losses and negative cash flows from operations. Therefore, there is substantial doubt about our ability to continue as a going concern for one year from the date the financials were issued.

 

45

 

 

At September 30, 2024, we had approximately $779,000 in cash and cash equivalents compared to $615,000 at December 31, 2023, which does not include any restricted funds. Our working capital (current assets minus current liabilities) was $337,000 at September 30, 2024 and ($349,000) at December 31, 2023.

 

As of September 30, 2024, we provided bank guarantees to various governmental bodies (approximately $971,000) and others (approximately $91,000) in respect of our drilling operation in the aggregate amount of approximately $1,062,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits restricted.

 

During the nine months ended September 30, 2024, cash used in operating activities totaled $5,102,000. Cash provided by financing activities during the nine months ended September 30, 2024 was $9,703,000 and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $4,389,000 for the nine months ended September 30, 2024.

 

During the nine months ended September 30, 2023, cash used in operating activities totaled $3,909,000. Cash provided by financing activities during the nine months ended September 30, 2023 was $4,370,000 and is primarily attributable to proceeds received from the Dividend Reinvestment and Stock Purchase Plan (the “DSPP” or the “Plan”). Net cash used in investing activities such as unproved oil and gas properties, equipment and spare parts was $2,045,000 for the nine months ended September 30, 2023.

 

Accounting standards require management to evaluate our ability to continue as a going concern for a period of one year subsequent to the date of the filing of this Form 10-Q. We expect to incur additional significant expenditures to further our exploration and development programs. While we raised approximately $1,319,000 during the period October 1, 2024 through November 6, 2024, we will need to raise additional funds in order to continue our exploration and development activities in our license area. Additionally, we estimate that, when we are not actively drilling a well, our expenditures are approximately $600,000 per month excluding exploratory operational activities. However, when we are actively drilling a well, we estimate an additional minimum expenditure of approximately $2,500,000 per month. The above estimates are subject to change. Subject to the qualifications specified below, management believes that our existing cash balance, coupled with anticipated proceeds under the DSPP, will be sufficient to finance our plan of operations through December 2024.

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

Similar uncertainties are posed by the Israel-Hamas war, as well as the Israel-Hezbollah war. The duration of both wars and its impact on the region and world is not fully known at this point in time. As stated previously in this report, our operations are paused, and our rig crew workers are safely out of Israel and at home.

 

No assurance can be provided that we will be able to raise the needed operating capital.

 

Even if we raise the needed funds, there are factors that can nevertheless adversely impact our ability to fund our operating needs, including (without limitation), the potential impact of the Israel-Hamas war, the Israel-Hezbollah war, the potential actions of other hostile parties in the region, unexpected or unforeseen cost overruns in planned non-drilling exploratory work in existing license areas, the costs associated with extended delays in undertaking the required exploratory work, and plugging and abandonment activities which is typical of what we have experienced in the past.

 

The financial information contained in these consolidated condensed financial statements has been prepared on a basis that assumes that we will continue as a going concern for one year from the date the financials were issued, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. This financial information and these consolidated condensed financial statements do not include any adjustments that may result from the outcome of this uncertainty.

 

Off-Balance Sheet Arrangements

 

We do not currently use any off-balance sheet arrangements to enhance our liquidity or capital resource position, or for any other purpose.

 

Recently Issued Accounting Pronouncements

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our financial position, results of operations, or cash flow.

 

46

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through September 30, 2024, the USD has fluctuated by approximately 2.3% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At September 30, 2024 we had cash, cash equivalents and short-term and long-term bank deposits of approximately $1,847,000. The weighted average annual interest rate related to our cash and cash equivalents for the three and nine months ended September 30, 2024, exclusive of funds at US banks that earn no interest, was approximately 2.8% and 2.9% respectively.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

 

ITEM 4. CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms. As of September 30, 2024, our chief executive officer and our chief financial officer conducted an evaluation of the effectiveness of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and our chief financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2024.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in internal controls over financial reporting that occurred during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

47

 

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes.

 

The Company is not subject to any litigation at the present time.

 

ITEM 1A. RISK FACTORS

 

During the quarter ended September 30, 2024, with the exception of the Israel-Hezbollah war, there were no material changes to the risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2023.

 

ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5. OTHER INFORMATION:

 

None.

 

48

 

 

ITEM 6. EXHIBITS

 

Exhibit Index:

 

31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
31.2   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 under the Exchange Act
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished only)
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

49

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

ZION OIL & GAS, INC.    
(Registrant)    
     
By: /s/ Robert W.A. Dunn   By: /s/ Michael B. Croswell Jr.
  Robert W. A. Dunn     Michael B. Croswell Jr.
  Chief Executive Officer     Chief Financial Officer
  (Principal Executive Officer)     (Principal Financial and Accounting Officer)
         
Date: November 7, 2024   Date: November 7, 2024

 

 

50

 

 

NONE P1Y false --12-31 Q3 0001131312 001-33228 0001131312 2024-01-01 2024-09-30 0001131312 2024-11-05 0001131312 2024-09-30 0001131312 2023-12-31 0001131312 2024-07-01 2024-09-30 0001131312 2023-07-01 2023-09-30 0001131312 2023-01-01 2023-09-30 0001131312 us-gaap:CommonStockMember 2023-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001131312 us-gaap:ReceivablesFromStockholderMember 2023-12-31 0001131312 us-gaap:RetainedEarningsMember 2023-12-31 0001131312 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001131312 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001131312 us-gaap:ReceivablesFromStockholderMember 2024-01-01 2024-09-30 0001131312 us-gaap:CommonStockMember 2024-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001131312 us-gaap:ReceivablesFromStockholderMember 2024-09-30 0001131312 us-gaap:RetainedEarningsMember 2024-09-30 0001131312 us-gaap:CommonStockMember 2024-06-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001131312 us-gaap:ReceivablesFromStockholderMember 2024-06-30 0001131312 us-gaap:RetainedEarningsMember 2024-06-30 0001131312 2024-06-30 0001131312 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001131312 us-gaap:ReceivablesFromStockholderMember 2024-07-01 2024-09-30 0001131312 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001131312 us-gaap:CommonStockMember 2022-12-31 0001131312 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001131312 us-gaap:RetainedEarningsMember 2022-12-31 0001131312 2022-12-31 0001131312 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001131312 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001131312 us-gaap:CommonStockMember 2023-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001131312 us-gaap:RetainedEarningsMember 2023-09-30 0001131312 2023-09-30 0001131312 us-gaap:CommonStockMember 2023-06-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001131312 us-gaap:RetainedEarningsMember 2023-06-30 0001131312 2023-06-30 0001131312 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001131312 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001131312 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001131312 znogw:NewMegiddoValleysLicenseMember znogw:MJ01ProjectMember 2023-09-14 0001131312 znogw:NewMegiddoValleysLicenseMember 2023-09-14 2023-09-14 0001131312 znogw:MJ01ProjectMember 2024-09-30 0001131312 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001131312 2023-01-01 2023-12-31 0001131312 2020-03-12 0001131312 znogw:I35DrillingRigMember 2020-03-12 0001131312 znogw:RigSparePartsMember 2024-01-01 2024-09-30 0001131312 znogw:DrillingPipeAndAccessoriesMember 2024-01-01 2024-09-30 0001131312 znogw:I35DrillingRigMember 2023-12-31 0001131312 znogw:RigSparePartsMember 2023-12-31 0001131312 znogw:OtherDrillingAssetsMember 2023-12-31 0001131312 znogw:I35DrillingRigMember 2024-01-01 2024-09-30 0001131312 znogw:OtherDrillingAssetsMember 2024-01-01 2024-09-30 0001131312 znogw:I35DrillingRigMember 2024-09-30 0001131312 znogw:RigSparePartsMember 2024-09-30 0001131312 znogw:OtherDrillingAssetsMember 2024-09-30 0001131312 znogw:I35DrillingRigMember 2022-12-31 0001131312 znogw:RigSparePartsMember 2022-12-31 0001131312 znogw:OtherDrillingAssetsMember 2022-12-31 0001131312 znogw:I35DrillingRigMember 2023-01-01 2023-12-31 0001131312 znogw:RigSparePartsMember 2023-01-01 2023-12-31 0001131312 znogw:OtherDrillingAssetsMember 2023-01-01 2023-12-31 0001131312 2023-06-07 0001131312 srt:MinimumMember 2023-06-07 0001131312 srt:MaximumMember 2023-06-07 0001131312 znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2021-06-09 2021-06-09 0001131312 znogw:FiveSeniorOfficersAndTwoStaffMembersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-01-01 2024-09-30 0001131312 znogw:FiveSeniorOfficersAndTwoStaffMembersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-09-30 0001131312 znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-01-01 2024-09-30 0001131312 znogw:OneSeniorOfficersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-01-01 2024-09-30 0001131312 znogw:OneSeniorOfficersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-09-30 0001131312 znogw:OneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-01-01 2024-09-30 0001131312 znogw:OneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-09-30 0001131312 znogw:FiveSeniorOfficersAndOneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:FiveSeniorOfficersAndOneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:OneSeniorOfficersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:OneSeniorOfficersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:OneBoardMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:OneBoardMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:OneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:OneStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:FiveStaffMembersAndOneSeniorOfficerMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:FiveStaffMembersAndOneSeniorOfficerMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:FourSeniorOfficersAndNineStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:FourSeniorOfficersAndNineStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:FourSeniorOfficersAndNineStaffMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2024-01-01 2024-09-30 0001131312 znogw:NineBoardMembersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:NineBoardMembersMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:ThreeConsultantsMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-01-01 2023-09-30 0001131312 znogw:ThreeConsultantsMember znogw:TwentyTwentyOneOmnibusIncentiveStockOptionPlanMember 2023-09-30 0001131312 znogw:ZNWADMember 2020-09-15 2020-09-15 0001131312 znogw:ZNWADMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAEWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAFWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAGWarrantMember 2022-12-14 2022-12-14 0001131312 znogw:ZNWAGWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAHWarrantMember 2020-09-15 2020-09-15 0001131312 znogw:ZNWAHWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAJWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAKWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWALWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAMWarrantMember 2024-01-01 2024-09-30 0001131312 us-gaap:CommonStockMember 2022-03-21 2022-03-21 0001131312 znogw:ZNWAMWarrantMember 2024-09-30 0001131312 znogw:ZNWAOWarrantsMember 2024-09-30 0001131312 znogw:ZNWAPWarrantMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWAPWarrantMember 2024-09-30 0001131312 znogw:ZnwapWarrantMember 2022-03-21 2022-03-21 0001131312 znogw:ZnwapWarrantMember 2022-06-30 0001131312 znogw:ZNWAQWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAQWarrantsMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWAQWarrantsMember 2024-09-30 0001131312 znogw:ZNWARWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWARWarrantMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWARWarrantMember 2024-09-30 0001131312 znogw:ZNWARWarrantMember 2021-01-01 2021-12-31 0001131312 2022-03-21 2022-03-21 0001131312 2022-06-30 0001131312 znogw:ZNWASWarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWASWarrantMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWASWarrantMember 2024-09-30 0001131312 znogw:ZNWATWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWATWarrantsMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWATWarrantsMember 2024-09-30 0001131312 znogw:ZNWAUWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAUWarrantsMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWAUWarrantsMember 2024-09-30 0001131312 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001131312 srt:ScenarioForecastMember 2024-12-31 0001131312 us-gaap:WarrantMember 2024-04-01 0001131312 2024-04-01 2024-04-01 0001131312 2023-03-13 2023-03-13 0001131312 znogw:UnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:WarrantsMember 2024-09-30 0001131312 znogw:WarrantsMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:ZNWAYWarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAYMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:WarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 srt:MinimumMember znogw:ZNWAYMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWAYMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAYMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAYWarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2023-06-28 0001131312 znogw:ZNWAWWarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2023-07-13 0001131312 znogw:ZNWAXWarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2023-07-31 0001131312 znogw:ZNWAYWarrantsMember znogw:AmendmentNo2NewUnitOptionUnderTheUnitProgramMember 2023-09-10 0001131312 us-gaap:WarrantMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember us-gaap:CommonStockMember 2024-09-30 0001131312 us-gaap:WarrantMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001131312 znogw:OTCQXWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAZWarrantsMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember us-gaap:CommonStockMember 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember us-gaap:WarrantMember znogw:ZNWAZWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAZWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:ZNWAZWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAZWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-07-17 0001131312 znogw:UnitOptionProgramMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember us-gaap:CommonStockMember 2024-09-30 0001131312 us-gaap:WarrantMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001131312 znogw:OTCBMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:ZnwakWarrantsMember znogw:AmendmentNo3NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWBAWarrantsMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAEWarrantsMember us-gaap:WarrantMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2024-01-01 2024-09-30 0001131312 srt:ScenarioForecastMember znogw:ZNWBAWarrantsMember znogw:AmendmentNo4NewUnitOptionUnderTheUnitProgramMember 2025-01-15 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ExtensionOfTerminationDateToDecember312024Member 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember znogw:ExtensionOfTerminationDateToDecember312024Member 2024-01-01 2024-09-30 0001131312 znogw:UnitOptionMember znogw:ExtensionOfTerminationDateToDecember312024Member 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember us-gaap:WarrantMember znogw:UnitOptionMember 2024-01-01 2024-09-30 0001131312 znogw:DividendReinvestmentAndCommonStockPurchasePlanMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember znogw:UnitOptionMember znogw:DividendReinvestmentAndCommonStockPurchasePlanMember 2024-01-01 2024-09-30 0001131312 us-gaap:WarrantMember 2024-09-30 0001131312 znogw:WarrantsMember znogw:DividendReinvestmentAndCommonStockPurchasePlanMember 2024-01-01 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:DividendReinvestmentAndCommonStockPurchasePlanMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember znogw:DividendReinvestmentAndCommonStockPurchasePlanMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member znogw:WarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member us-gaap:WarrantMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member us-gaap:WarrantMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMarch312024Member 2024-09-30 0001131312 znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToApril302024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToApril302024Member 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToApril302024Member znogw:WarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToApril302024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToApril302024Member znogw:ZNWBAWarrantsMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWBAWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member znogw:WarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToMay312024Member znogw:ZNWBAWarrantsMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember znogw:ZNWBAWarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member znogw:WarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToAugust312024Member znogw:ZNWBAWarrantsMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member znogw:WarrantsMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToOctober152024Member znogw:ZNWBAWarrantsMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member znogw:AutomaticMonthlyInvestmentsAMIProgramMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member znogw:WarrantsMember 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2024-07-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2023-07-01 2023-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2023-01-01 2023-09-30 0001131312 2024-10-01 2024-11-06 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:CommonStockMember 2018-04-02 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2018-04-02 2018-04-02 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:WarrantMember 2018-04-02 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member znogw:SubscriptionRightsOfferingMember 2020-06-29 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2018-12-04 2018-12-04 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2019-05-29 2019-05-29 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2020-09-15 2020-09-15 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member znogw:SubscriptionRightsOfferingMember 2024-01-01 2024-09-30 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:WarrantMember 2019-05-19 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2020-09-15 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:WarrantMember 2022-03-21 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:WarrantMember 2022-12-14 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member 2022-12-28 0001131312 znogw:ExtensionOfTerminationDateToDecember312024Member us-gaap:WarrantMember 2024-01-10 0001131312 us-gaap:EmployeeStockMember 2023-12-31 0001131312 us-gaap:EmployeeStockMember 2024-01-01 2024-09-30 0001131312 us-gaap:EmployeeStockMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesOneMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesOneMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesOneMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesOneMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwoMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwoMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwoMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwoMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThreeMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThreeMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThreeMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThreeMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiveMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiveMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiveMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiveMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSixMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSixMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSixMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSixMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSevenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSevenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSevenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSevenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesEightMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesEightMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesEightMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesEightMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesNineMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesNineMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesNineMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesNineMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesElevenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesElevenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesElevenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesElevenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwelveMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwelveMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwelveMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwelveMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFifteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFifteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFifteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFifteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSixteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSixteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSixteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSixteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSeventeenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesSeventeenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSeventeenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesSeventeenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesEighteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesEighteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesEighteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesEighteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesNineteenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesNineteenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesNineteenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesNineteenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyOneMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyOneMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyOneMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyOneMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyTwoMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyTwoMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyThreeMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyThreeMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyFourMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyFourMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyFourMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyFourMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyFiveMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyFiveMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentySixMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentySixMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentySixMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentySixMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentySevenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentySevenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentySevenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentySevenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyEightMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyEightMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyEightMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyEightMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyNineMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesTwentyNineMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyNineMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesTwentyNineMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyOneMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyOneMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyOneMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyOneMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyTwoMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyTwoMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyThreeMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyThreeMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyFourMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyFourMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyFourMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyFourMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyFiveMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyFiveMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtySixMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtySixMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtySixMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtySixMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtySevenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtySevenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtySevenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtySevenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyEightMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyEightMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyEightMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyEightMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyNineMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesThirtyNineMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyNineMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesThirtyNineMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyOneMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyOneMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyOneMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyOneMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyTwoMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyTwoMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyTwoMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyThreeMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyThreeMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyThreeMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyFourMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyFourMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyFourMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyFourMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyFiveMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyFiveMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyFiveMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtySixMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtySixMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtySixMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtySixMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtySevenMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtySevenMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtySevenMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtySevenMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyEightMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyEightMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyEightMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyEightMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyNineMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFourtyNineMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyNineMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFourtyNineMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiftyMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiftyMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiftyMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiftyMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiftyOneMember 2024-09-30 0001131312 znogw:NonVestedMember znogw:RangesFiftyOneMember 2024-01-01 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiftyOneMember 2024-09-30 0001131312 znogw:VestedMember znogw:RangesFiftyOneMember 2024-01-01 2024-09-30 0001131312 znogw:NonVestedMember 2024-09-30 0001131312 srt:MinimumMember znogw:VestedMember 2024-09-30 0001131312 srt:MaximumMember znogw:VestedMember 2024-09-30 0001131312 znogw:VestedMember 2024-09-30 0001131312 znogw:EmployeesAndDirectorsMember 2024-01-01 2024-09-30 0001131312 znogw:EmployeesAndDirectorsMember 2023-01-01 2023-09-30 0001131312 srt:MinimumMember znogw:EmployeesAndDirectorsMember 2024-01-01 2024-09-30 0001131312 srt:MaximumMember znogw:EmployeesAndDirectorsMember 2024-01-01 2024-09-30 0001131312 srt:MinimumMember znogw:EmployeesAndDirectorsMember 2023-01-01 2023-09-30 0001131312 srt:MaximumMember znogw:EmployeesAndDirectorsMember 2023-01-01 2023-09-30 0001131312 znogw:NonEmployeesMember 2024-01-01 2024-09-30 0001131312 znogw:NonEmployeesMember 2023-01-01 2023-09-30 0001131312 znogw:EmployeesAndDirectorsMember 2024-07-01 2024-09-30 0001131312 znogw:EmployeesAndDirectorsMember 2023-07-01 2023-09-30 0001131312 znogw:NonEmployeesMember 2024-07-01 2024-09-30 0001131312 znogw:NonEmployeesMember 2023-07-01 2023-09-30 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2024-09-30 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAAMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAGMember znogw:WarrantTransactionsMember 2024-09-30 0001131312 znogw:ZNWAGMember znogw:WarrantTransactionsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAGMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2024-09-30 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAMMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAQMember znogw:WarrantTransactionsMember 2024-09-30 0001131312 znogw:ZNWAQMember znogw:WarrantTransactionsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAQMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZNWAZMember znogw:WarrantTransactionsMember 2024-09-30 0001131312 znogw:ZNWAZMember znogw:WarrantTransactionsMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAZMember znogw:WarrantTransactionsMember 2023-12-31 0001131312 znogw:ZnwaaWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZnwaaWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZnwamWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZnwamWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZNWAQWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAQWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZnwasWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZnwasWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZnwatWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZnwatWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZNWAUWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWAUWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember us-gaap:InvestorMember 2024-01-01 2024-09-30 0001131312 znogw:ZNWBAWarrantsMember us-gaap:InvestorMember 2024-09-30 0001131312 country:IL 2024-09-30 0001131312 us-gaap:UseRightsMember 2024-07-01 2024-09-30 0001131312 us-gaap:UseRightsMember 2024-01-01 2024-09-30 0001131312 us-gaap:UseRightsMember 2023-07-01 2023-09-30 0001131312 us-gaap:UseRightsMember 2023-01-01 2023-09-30 0001131312 us-gaap:UseRightsMember 2023-07-01 2023-09-30 0001131312 us-gaap:UseRightsMember 2023-01-01 2023-09-30 0001131312 2023-11-16 0001131312 2023-11-16 2023-11-16 0001131312 2023-12-16 2023-12-16 0001131312 2023-12-28 0001131312 2023-12-13 2023-12-13 0001131312 2024-01-28 2024-01-28 0001131312 2024-03-12 0001131312 2024-02-23 2024-02-23 0001131312 2024-04-12 2024-04-12 0001131312 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember znogw:FourSuppliersMember 2024-01-01 2024-09-30 0001131312 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember znogw:ThreeSuppliersMember 2024-01-01 2024-09-30 0001131312 znogw:DSPPProgramMember us-gaap:SubsequentEventMember 2024-10-01 2024-11-06 xbrli:shares iso4217:USD iso4217:USD xbrli:shares utr:acre utr:sqkm utr:sqft xbrli:pure

Exhibit 31.1

 

 CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Robert W. A. Dunn, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 7, 2024  
   
/s/ Robert W. A. Dunn  
Robert W. A. Dunn, Chief Executive Officer  
(Principal Executive Officer)  

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Michael B. Croswell Jr, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Zion Oil & Gas, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuer’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 7, 2024  
   
/s/ Michael B. Croswell Jr.  
Michael B. Croswell Jr, Chief Financial Officer  
(Principal Financial and Accounting Officer)    

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Zion Oil and Gas, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2024 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Robert W.A. Dunn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Robert W.A. Dunn  
Robert W. A. Dunn  
Chief Executive Officer  
(Principal Executive Officer)  
   
November 7, 2024  

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Zion Oil and Gas, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2024 (the "Report"), as filed with the Securities and Exchange Commission on the date hereof, I, Michael B. Croswell Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods presented in the Report.

 

/s/ Michael B. Croswell Jr.  
Michael B. Croswell Jr.  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  
   
November 7, 2024  
v3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Nov. 05, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Information [Line Items]    
Entity Registrant Name ZION OIL & GAS, INC.  
Entity Central Index Key 0001131312  
Entity File Number 001-33228  
Entity Tax Identification Number 20-0065053  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 12655 N Central Expressway  
Entity Address, Address Line Two Suite 1000  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75243  
Entity Phone Fax Numbers [Line Items]    
City Area Code (214)  
Local Phone Number 221-4610  
Entity Listings [Line Items]    
Title of 12(b) Security N/A  
No Trading Symbol Flag true  
Security Exchange Name NONE  
Entity Common Stock, Shares Outstanding   934,359,384
v3.24.3
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 779 $ 615
Fixed short term bank and escrow deposits – restricted 1,068 1,020
Prepaid expenses and other 257 515
Governmental receivables 173 18
Other receivables 140 123
Total current assets 2,417 2,291
Unproved oil and gas properties, full cost method (see Note 4) 21,033 16,637
Property and equipment at cost    
Drilling rig and related equipment, net of accumulated depreciation of $2,627 and $2,215 (see note 2I) 4,958 5,510
Property and equipment, net of accumulated depreciation of $707 and $686 112 74
Property and equipment, net 5,070 5,584
Right of Use Lease Assets (see Note 5) 826 194
Other assets    
Assets held for severance benefits 520 475
Total other assets 520 475
Total assets 29,866 25,181
Current liabilities    
Accounts payable 827 777
Insurance financing (see note 6D) 75 432
Lease obligation – current (see Note 5) 145 167
Asset retirement obligation 571 571
Accrued liabilities 462 693
Total current liabilities 2,080 2,640
Long-term liabilities    
Lease obligation – non-current (see Note 5) 652 24
Provision for severance pay 529 499
Total long-term liabilities 1,181 523
Total liabilities 3,261 3,163
Commitments and contingencies (see Note 6)
Stockholders’ equity    
Common stock, par value $.01; Authorized: 1,200,000,000 shares at September 30, 2024: Issued and outstanding: 880,562,128 and 640,002,580 shares at September 30, 2024 and December 31, 2023, respectively 8,806 6,400
Additional paid-in capital 309,975 302,177
Accumulated deficit (292,176) (286,559)
Total stockholders’ equity 26,605 22,018
Total liabilities and stockholders’ equity $ 29,866 $ 25,181
v3.24.3
Consolidated Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Drilling rig and related equipment, net of accumulated depreciation (in Dollars) $ 2,627 $ 2,215
Accumulated depreciation (in Dollars) $ 707 $ 686
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 1,200,000,000 1,200,000,000
Common stock, shares issued 880,562,128 640,002,580
Common stock, shares outstanding 880,562,128 640,002,580
v3.24.3
Consolidated Condensed Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
General and administrative $ 1,143 $ 1,332 $ 3,519 $ 4,106
Post impairment of unproved oil and gas properties 36 129
Other 632 379 2,113 1,978
Loss from operations (1,775) (1,747) (5,632) (6,213)
Other income (expense), net        
Foreign exchange income (loss) (20) 2 11 (2)
Financial income (expenses), net 4 2 4 (1)
Loss, before income taxes (1,791) (1,743) (5,617) (6,216)
Income taxes
Net loss $ (1,791) $ (1,743) $ (5,617) $ (6,216)
Net loss per share of common stock        
Net loss per share of common stock basic (in Dollars per share) $ 0 $ 0 $ (0.01) $ (0.01)
Net loss per share of common stock diluted (in Dollars per share) $ 0 $ 0 $ (0.01) $ (0.01)
Weighted-average shares outstanding        
Weighted-average shares outstanding basic (in Shares) 843,211 578,497 752,241 551,551
Weighted-average shares outstanding diluted (in Shares) 843,211 578,497 752,241 551,551
v3.24.3
Consolidated Condensed Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in Capital
Subscription Receivables
Accumulated deficit
Total
Balances at Dec. 31, 2022 $ 5,242 $ 296,460   $ (278,602) $ 23,100
Balances (in Shares) at Dec. 31, 2022 524,231,000        
Funds received from sale of DSPP units and shares and exercise of warrants $ 782 4,186   4,968
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 78,173,000        
Funds received from option exercises $ 2 10   12
Funds received from option exercises (in Shares) 150,000        
Costs associated with the issuance of shares (610)   (610)
Value of options granted to employees, directors and others as non-cash compensation 923   923
Net loss   (6,216) (6,216)
Balances at Sep. 30, 2023 $ 6,026 300,969   (284,818) 22,177
Balances (in Shares) at Sep. 30, 2023 602,554,000        
Balances at Jun. 30, 2023 $ 5,604 299,321   (283,075) 21,850
Balances (in Shares) at Jun. 30, 2023 560,449,000        
Funds received from sale of DSPP units and shares and exercise of warrants $ 422 1,820   2,242
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 42,105,000        
Funds received from option exercises  
Costs associated with the issuance of shares (437)   (437)
Value of options granted to employees, directors and others as non-cash compensation 265   265
Net loss   (1,743) (1,743)
Balances at Sep. 30, 2023 $ 6,026 300,969   (284,818) 22,177
Balances (in Shares) at Sep. 30, 2023 602,554,000        
Balances at Dec. 31, 2023 $ 6,400 302,177 (286,559) $ 22,018
Balances (in Shares) at Dec. 31, 2023 640,002,000       640,002,580
Funds received from sale of DSPP units and shares and exercise of warrants $ 2,405 9,755   $ 12,160
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 240,422,000        
Funds received from option exercises $ 1 8 9
Funds received from option exercises (in Shares) 138,000        
Costs associated with the issuance of shares (2,299) (2,299)
Value of options granted to employees, directors and others as non-cash compensation 334 334
Net loss (5,617) (5,617)
Balances at Sep. 30, 2024 $ 8,806 309,975 (292,176) $ 26,605
Balances (in Shares) at Sep. 30, 2024 880,562,000       880,562,128
Balances at Jun. 30, 2024 $ 8,189 308,319 (985) (290,385) $ 25,138
Balances (in Shares) at Jun. 30, 2024 818,874,000        
Funds received from sale of DSPP units and shares and exercise of warrants $ 617 2,090 985 3,692
Funds received from sale of DSPP units and shares and exercise of warrants (in Shares) 61,646,000        
Funds received from option exercises  
Funds received from option exercises (in Shares) 42,000        
Costs associated with the issuance of shares (536) (536)
Value of options granted to employees, directors and others as non-cash compensation 102 102
Net loss (1,791) (1,791)
Balances at Sep. 30, 2024 $ 8,806 $ 309,975 $ (292,176) $ 26,605
Balances (in Shares) at Sep. 30, 2024 880,562,000       880,562,128
v3.24.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (5,617) $ (6,216)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Depreciation 598 601
Amortization of Right of Use Lease Assets 197 208
Cost of options issued to employees, directors and others as non-cash compensation 334 923
Post impairment of unproved oil and gas properties 129
Loss on sale of property and equipment 63
Other deposits 483
Prepaid expenses and other 258 367
Governmental receivables (155) 257
Lease obligation – current and non-current (223) (215)
Other receivables (17) (13)
Severance payable, net (15) (2)
Accounts payable (440) (300)
Accrued liabilities (85) (131)
Net cash used in operating activities (5,102) (3,909)
Cash flows from investing activities    
Acquisition of property and equipment (59)
Proceeds from sale of property and equipment 35
Acquisition of drilling rig and related equipment (178)
Investment in unproved oil and gas properties (4,187) (2,045)
Net cash used in investing activities (4,389) (2,045)
Cash flows from financing activities    
Proceeds from exercise of stock options 9 12
Costs paid related to the issuance of new shares (2,466) (610)
Proceeds from issuance of stock and exercise of warrants 12,160 4,968
Net cash provided by financing activities 9,703 4,370
Net (decrease)/increase in cash, cash equivalents and restricted cash 212 (1,584)
Cash, cash equivalents and restricted cash – beginning of period 1,635 3,114
Cash, cash equivalents and restricted cash – end of period 1,847 1,530
Non-cash investing and financing activities:    
Unpaid investments in oil & gas properties 840 677
Unpaid Costs associated with the issuance of shares 167
Depreciation of oil and gas equipment 16
Addition of right of use lease assets and lease obligations $ 829 $ 252
v3.24.3
Consolidated Condensed Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Statement of Cash Flows [Abstract]    
Cash and cash equivalents $ 779 $ 615
Restricted cash included in fixed long-term bank deposits 1,068 1,020
Total restricted cash $ 1,847 $ 1,635
v3.24.3
Nature of Operations, Basis of Presentation and Going Concern
9 Months Ended
Sep. 30, 2024
Nature of Operations, Basis of Presentation and Going Concern [Abstract]  
Nature of Operations, Basis of Presentation and Going Concern

Note 1 - Nature of Operations, Basis of Presentation and Going Concern

 

A. Nature of Operations 

 

Zion Oil & Gas, Inc., a Delaware corporation (“we,” “our,” “Zion” or the “Company”) is an oil and gas exploration company with a history of 24 years of oil & gas exploration in Israel. As of September 30, 2024, the Company has no revenues from its oil and gas operations.

 

Zion maintains its corporate headquarters in Dallas, Texas. The Company also has branch offices in Caesarea, Israel and Geneva, Switzerland. The purpose of the Israel branch is to support the Company’s operations in Israel, and the purpose of the Switzerland branch is to operate a foreign treasury center for the Company.

 

On January 24, 2020, Zion incorporated a wholly owned subsidiary, Zion Drilling, Inc., a Delaware corporation, for the purpose of owning a drilling rig, related equipment and spare parts, and on January 31, 2020, Zion incorporated another wholly owned subsidiary, Zion Drilling Services, Inc., a Delaware corporation, to act as the contractor providing such drilling services. When Zion is not using the rig for its own exploration activities, Zion Drilling Services may contract with other operators in Israel to provide drilling services at market rates then in effect.

 

Zion has the trademark “ZION DRILLING” filed with the United States Patent and Trademark Office. Zion has the trademark filed with the World Intellectual Property Organization in Geneva, Switzerland, pursuant to the Madrid Agreement and Protocol. In addition, Zion has the trademark filed with the Israeli Trademark Office in Israel.

 

Exploration Rights/Exploration Activities

 

New Megiddo Valleys License 434 (“NMVL 434”) – Megiddo-Jezreel #1 Re-Entry (“MJ-01”)

 

On September 14, 2023, the Israel Ministry of Energy approved a new Megiddo Valleys License 434 (“NMVL 434”), allowing for oil and gas exploration on approximately 75,000 acres or 302 square kilometers. This Exploration License 434 is valid for three years until September 13, 2026 with four potential 1-year extensions for a total of seven years until September 13, 2030. This NMVL 434 effectively supersedes our previous NML 428.

  

On February 21, 2024, members of the Supervisory Committee visited our rig site. During this visit, they interacted with staff from Zion Oil & Gas, our consultants and potential service providers. Some of these interactions occurred at Kibbutz Sde Eliyahu, while others were conducted through video conferencing with participants from the United States, Europe and the Middle East. Following these discussions, the Committee officially accepted our work plan for the MJ-01 re-completion project. This acceptance allowed us to sign agreements and secure mobilization dates with our service providers to commence and complete the project.

 

The initial phase of our recompletion project consisted of a category three inspection of the drilling rig, rigging down from MJ-02 and moving and rigging up over the MJ-01 well.

 

Stage two of the operation involved drilling out both the steel plugs along with 625 meters (about 2,050 feet) of cement plugs and re-conditioning the wellbore to allow unhindered access to the selected zones for testing.

 

After six years of inactivity in a well over three miles deep, the MJ-01 wellbore presents a challenging environment. The crew appears to have experienced elastic and partial collapse of the casing in some areas. This led to the bottom hole assembly (“BHA”) becoming stuck over 4,000 meters from surface. Attempts to overpull the BHA were unsuccessful, and the crew completed a backoff operation which left over 500 meters of the BHA remaining downhole. This is not an uncommon occurrence with oil and gas drilling operations, but we do need to recover the “fish” to resume operations. The crew was unsuccessful in retrieving the remaining BHA with the tools that were on location and will require specialized tools and techniques to recover the entire fish. The specialized tools we need are not in Israel, but have been sourced, but not approved for mobilization due to the active conflict in Israel.

 

Another delay arose out of the logistical challenges we face. The ongoing conflict in the region has impacted shipping routes, the timely arrival of necessary equipment, and created travel difficulties for our rig crews. Our operations require specialized rig crews who are not available in Israel.

 

An even further delay has been created by many of our rig crew members reaching the limit of their work visas. This requires us to reset visas, which is not a simple process, and it adds another layer of delay and complexity. Moreover, the recent changes to visa eligibility have further complicated the process, as Israel, in just the last few months, has changed their 90-day visa renewals from resetting at the end of the year to resetting after six months after expiration. We are working with the Ministry of Interior on this issue. As a side note, the crew had to enter Israel under 90 day visas and not six month or 12 month visas in order to comply with the labor law requirements in place at the time the operation commenced.

 

In light of the combination of downhole, logistical, and crew challenges, as well as holidays, and the one-year remembrance of October 7, we have temporarily paused active operations. This is a necessary step to ensure the safety of our personnel and to ensure proper engineering and tools are brought to location to avoid lengthy delays waiting for additional tools should any be required once the job resumes. We anticipate that once we have the necessary tools and renewed visas for our crews, we can resume operations in Q4 2024 or Q1 2025. This is, of course, subject to the realities of the present geopolitical environment. The conflict in Israel, while not directly impacting our operations on a daily basis, creates uncertainties that could affect our schedule at any time.

 

While our MJ-01 re-completion project has faced a multitude of hurdles, including an active conflict, downhole issues and logistical challenges, we continue to move forward each time a safe opportunity permits continuation of operations. However, we will only move forward in coordination with Israeli authorities. We are actively monitoring the port situation to import the items needed to complete the current work program. We remain optimistic about making significant progress in the coming months.

 

B. Basis of Presentation 

 

The accompanying unaudited interim consolidated condensed financial statements of Zion Oil & Gas, Inc. have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with Article 8-03 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring accruals necessary for a fair statement of financial position, results of operations and cash flows, have been included. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the financial statements and the accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The year-end balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the operating results for the year ending December 31, 2024 or for any other subsequent interim period.

 

C. Going Concern 

 

The Company incurs cash outflows from operations, and all exploration activities and overhead expenses to date have been financed by way of equity or debt financing. The recoverability of the costs incurred to date is uncertain and dependent upon achieving significant commercial production of hydrocarbons. 

 

The Company’s ability to continue as a going concern is dependent upon obtaining the necessary financing to undertake further exploration and development activities and ultimately generating profitable operations from its oil and natural gas interests in the future. The Company’s current operations are dependent upon the adequacy of its current assets to meet its current expenditure requirements and the accuracy of management’s estimates of those requirements. Should those estimates be materially incorrect, the Company’s ability to continue as a going concern may be in doubt. The consolidated condensed financial statements have been prepared on a going concern basis, which contemplates realization of assets and liquidation of liabilities in the ordinary course of business. During the nine months ended September 30, 2024, the Company incurred a net loss of approximately $5.6 million and had an accumulated deficit of approximately $292 million. These factors raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date the financials were issued.

 

To carry out planned operations, the Company must raise additional funds through additional equity and/or debt issuances or through profitable operations. There can be no assurance that this capital or positive operational income will be available to the Company, and if it is not, the Company may be forced to curtail or cease exploration and development activities. The consolidated condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

v3.24.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

 

A. Net Loss per Share Data 

 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 33,337,132 in stock options and 29,303,152 in warrants would be anti-dilutive.

 

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 27,096,250 in stock options and 30,242,620 in warrants would be anti-dilutive.

 

B. Use of Estimates 

 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases, accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, political instability and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

Similar uncertainties are posed by the Israel-Hamas war, as well as the Israel-Lebanon war. The duration of both wars and its impact on the region and world is not fully known at this point in time. As stated previously in this report, our operations are paused and our rig crew workers are safely out of Israel and at home.

  

Actual results may differ from these estimates.

 

C. Oil and Gas Properties and Impairment 

 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

 

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

 

During the three and nine months ended September 30, 2024, the Company did not record any post-impairment charges.

 

During the three and nine months ended September 30, 2023, the Company recorded post-impairment charges of $36,000 and $129,000, respectively.

 

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $21,033,000 and $16,637,000 as of September 30, 2024 and December 31, 2023, respectively.

 

D. Fair Value Measurements 

 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;

 

  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and

 

  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At September 30, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

 

E. Stock-Based Compensation 

 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

F. Warrants 

 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

 

G. Related parties 

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

 

Zion did not have any related party transactions for the periods covered in this report.

 

H. Recently Adopted Accounting Pronouncements   

 

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

 

I. Depreciation and Accounting for Drilling Rig and Related Equipment

 

On March 12, 2020, Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

 

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

 

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

 

Zion purchased rig spare parts totaling approximately $178,000 during the year 2024 in preparation for its MJ-01 re-entry project.

 

Zion sold some excess scrap drilling pipe and accessories for approximately $35,000 to a local Israeli party during the year 2024. This transaction triggered a reduction in Other Drilling Assets, an accumulated depreciation adjustment and a loss on the disposal.

 

See the table below for a reconciliation of the rig-related activity during the period ended September 30, 2024:

 

I-35 Drilling Rig & Associated Equipment:

 

   Nine-months ended September 30, 2024 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    178    
-
    178 
Asset Depreciation   (476)   
-
    (118)   (594)
Asset Disposals   
-
    
-
    (97)   (97)
Asset Disposals for Self-Consumption   
-
    (39)   
-
    (39)
September 30, 2024   4,115    747    96    4,958 

 

   As of December 31, 2023 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2022   5,225    619    437    6,281 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (634)   
-
    (117)   (751)
Asset Disposals for Self-Consumption   
-
    (11)   
-
    (11)
December 31, 2023   4,591    608    311    5,510 
v3.24.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Stockholders’ Equity

Note 3 - Stockholders’ Equity

 

The Company’s shareholders approved the amendment of the Company’s Amended and Restated Certificate of Incorporation to increase the number of shares of common stock, par value $0.01, that the Company is authorized to issue from 800,000,000 shares to 1,200,000,000 shares, effective June 7, 2023.

 

A. 2021 Omnibus Incentive Stock Option Plan 

 

Effective June 9, 2021, the Company’s shareholders authorized the adoption of the Zion Oil & Gas, Inc. 2021 Omnibus Incentive Stock Option Plan (“Omnibus Plan”) for employees, directors and consultants, initially reserving for issuance thereunder 38,000,000 shares of common stock.

 

The Omnibus Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, bonus stock, awards in lieu of cash obligations, other stock-based awards and performance units. The plan also permits cash payments under certain conditions.

 

The compensation committee of the Board of Directors (comprised of independent directors) is responsible for determining the type of award, when and to whom awards are granted, the number of shares and the terms of the awards and exercise prices. The options are exercisable for a period not to exceed ten years from the date of grant.

 

During the nine months ended September 30, 2024, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to five senior officers and two staff members at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through January 4, 2034. The fair value of the options at the date of grant amounted to approximately $11,000.

 

  ii.

Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,800.

 

  iii.

Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2034. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $500.

 

During the nine months ended September 30, 2023, the Company granted the following options from the Omnibus Plan for employees, directors and consultants, to purchase shares of common stock as non-cash compensation:

 

  i. Options to purchase 175,000 shares of Common Stock to five senior officers and one staff member at an exercise price of $0.0615 per share. The options vested upon grant and are exercisable through January 4, 2033. The fair value of the options at the date of grant amounted to approximately $9,000.

 

  ii. Options to purchase 25,000 shares of Common Stock to one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through January 4, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $1,500.

 

  iii.

Options to purchase 25,000 shares of Common Stock to one board member, at an exercise price of $0.07 per share. The options vested upon grant and are exercisable through June 8, 2033. The fair value of the options at the date of grant amounted to approximately $1,500.

 

  iv.

Options to purchase 10,000 shares of Common Stock to one staff member at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 1, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $600.

 

  v.

Options to purchase 895,000 shares of Common Stock to five staff members and one senior officer at an exercise price of $0.01 per share. The options vested upon grant and are exercisable through September 23, 2033. These options were granted per the provisions of the Israeli Appendix to the Plan. The fair value of the options at the date of grant amounted to approximately $60,000

 

  vi.

Options to purchase 3,350,000 shares of Common Stock to four senior officers and nine staff members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $211,000, and was recognized during the years 2023 and 2024.

 

  vii.

Options to purchase 3,600,000 shares of Common Stock to nine board members at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $227,000, and was recognized during the years 2023 and 2024.

 

  viii. Options to purchase 55,000 shares of Common Stock to three consultants at an exercise price of $0.0676 per share. The options vest on September 23, 2024 (one year from the date of grant) and are exercisable through September 23, 2033. The fair value of the options at the date of grant amounted to approximately $3,000, and was recognized during the years 2023 and 2024.

 

B. Stock Options 

 

The stock option transactions since January 1, 2024 are shown in the table below:

 

   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   210,000    0.07 
Expired/Cancelled/Forfeited   (825,943)   1.72 
Exercised   (138,175)   0.07 
Outstanding, September 30, 2024   33,337,132    0.19 
Exercisable, September 30, 2024   33,337,132    0.19 

 

The following table summarizes information about stock options outstanding as of September 30, 2024:

 

Shares underlying outstanding options (non-vested)     Shares underlying outstanding options (fully vested)  
Range of
exercise
price
    Number
outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
    Range of
exercise
price
    Number
Outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
 
US$                 US$     US$                 US$  
                          0.01       107,500       2.25       0.01  
                          0.01       50,000       2.26       0.01  
                          0.01       60,000       2.55       0.01  
                          0.01       200,000       3.64       0.01  
                          0.01       40,000       3.00       0.01  
                          0.01       70,000       3.25       0.01  
                          0.01       25,000       3.26       0.01  
                          0.01       30,000       3.41       0.01  
                          0.01       4,000       3.52       0.01  
                          0.01       25,000       4.27       0.01  
                          0.01       35,000       5.97       0.01  
                          0.01       150,000       5.14       0.01  
                          0.01       35,000       4.97       0.01  
                          0.01       75,000       6.27       0.01  
                          0.01       200,000       6.64       0.01  
                          0.01       300,000       6.80       0.01  
                          0.01       10,000       6.92       0.01  
                          0.01       500,000       7.27       0.01  
                          0.01       55,000       7.30       0.01  
                          0.01       960,000       7.55       0.01  
                          0.01       75,000       7.87       0.01  
                          0.01       10,000       7.93       0.01  
                          0.01       795,000       7.99       0.01  
                          0.01       25,000       8.27       0.01  
                          0.01       10,000       8.93       0.01  
                          0.01       895,000       8.98       0.01  
                          0.01       25,000       9.27       0.01  
                          0.01       10,000       9.93       0.01  
                          0.06       50,000       8.27       0.06  
                          0.07       125,000       9.27       0.07  
                          0.07       6,980,000       8.99       0.07  
                          0.14       210,000       7.30       0.14  
                          0.15       3,200,000       7.27       0.15  
                          0.15       6,354,325       7.55       0.15  
                          0.16       340,000       1.19       0.16  
                          0.16       75,000       5.20       0.16  
                          0.18       25,000       1.17       0.18  
                          0.18       5,130,000       7.99       0.18  
                          0.24       25,000       7.84       0.24  
                          0.24       118,000       7.87       0.24  
                          0.25       50,000       6.92       0.25  
                          0.25       363,000       6.92       0.25  
                          0.28       25,000       0.93       0.28  
                          0.28       25,000       4.93       0.28  
                          0.29       25,000       2.71       0.29  
                          0.39       1,435,000       6.78       0.39  
                          0.59       1,400,000       2.64       0.59  
                          0.59       1,600,000       6.64       0.59  
                          0.92       350,000       2.26       0.92  
                          0.92       550,000       6.27       0.92  
                          1.38       105,307       0.26       1.38  
                              0.01-1.38       33,337,132               0.19  

 

Granted to employees  

 

The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.07 
Dividend yields   
    
 
Expected volatility   133%-134%   135%-137%
Risk-free interest rates   3.71%-3.97%   3.85%-4.61%
Expected lives (in years)   5.00    5.00-5.50 
Weighted-average grant date fair value  $0.07   $0.06 

 

Granted to non-employees

 

The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:

 

   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date   
   $0.07 
Dividend yields   
    
 
Expected volatility   
    134%
Risk-free interest rates   
    4.1%
Expected lives (in years)   
    10 
Weighted-average grant date fair value   
   $0.05 

 

C. Compensation Cost for Warrant and Option Issuances   

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:

 

For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  101       264  

 

 For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  331       921  

 

The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:

 

For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  1        

 

For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  3       2  

 

D. Dividend Reinvestment and Stock Purchase Plan (“DSPP”)

 

On March 13, 2014 Zion filed a registration statement on Form S-3 that was part of a replacement registration statement that was filed with the SEC using a “shelf” registration process. The registration statement was declared effective by the SEC on March 31, 2014. On February 23, 2017, the Company filed a Form S-3 with the SEC (Registration No. 333-216191) as a replacement for the Form S-3 (Registration No. 333-193336), for which the three-year period ended March 31, 2017, along with the base Prospectus and Supplemental Prospectus. The Form S-3, as amended, and the new base Prospectus became effective on March 10, 2017, along with the Prospectus Supplement that was filed and became effective on March 10, 2017. The Prospectus Supplement under Registration No. 333-216191 describes the terms of the DSPP and replaces the prior Prospectus Supplement, as amended, under the prior Registration No. 333-193336.

 

On September 15, 2020, the Company extended the termination date of the ZNWAD Warrant by two (2) years from the expiration date of May 2, 2021 to May 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 2, 2023, any outstanding ZNWAD warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAE Warrant by two (2) years from the expiration date of May 1, 2021 to May 1, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of May 1, 2023, any outstanding ZNWAE warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAF Warrant by two (2) years from the expiration date of August 14, 2021 to August 14, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 14, 2023, any outstanding ZNWAF warrants expired.

 

On December 14, 2022, the Company extended the termination date of the ZNWAG warrant by one (1) year from the expiration date of January 8, 2023 to January 8, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of January 8, 2024, any outstanding ZNWAG warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAH Warrant by two (2) years from the expiration date of April 2, 2021 to April 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of April 2, 2023, any outstanding ZNWAH warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAJ Warrant by two (2) years from the expiration date of October 29, 2021 to October 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 29, 2023, any outstanding ZNWAJ warrants expired.

  

On September 15, 2020, the Company extended the termination date of the ZNWAK warrant by two (2) years from the expiration date of February 25, 2021 to February 25, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of February 25, 2023, any outstanding ZNWAK warrants expired.

 

On September 15, 2020, the Company extended the termination date of the ZNWAL Warrant by two (2) years from the expiration date of August 26, 2021 to August 26, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of August 26, 2023, any outstanding ZNWAL warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed Waiver Term Sheets of a unit option program consisting of a Unit (shares of stock and warrants) of its securities and subsequently an option program consisting of shares of stock to a participant. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAM.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants became exercisable on January 15, 2021 and continue to be exercisable through July 15, 2022.

 

On March 21, 2022, the Company extended the termination date of the ZNWAM warrant by one (1) year from the expiration date of July 15, 2022 to July 15, 2023 and revised the exercise price to $0.05. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAM warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAM warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAM warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAM warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAM warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

The ZNWAN warrants became exercisable on May 16, 2021 and continued to be exercisable through May 16, 2023 at a per share exercise price of $1.00.

 

As of May 16, 2023, any outstanding ZNWAN warrants expired.

 

The ZNWAO warrants became exercisable on June 12, 2021 and continued to be exercisable through June 12, 2023 at a per share exercise price of $.25.

 

As of June 12, 2023, any outstanding ZNWAO warrants expired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a program consisting of Zion securities to a participant. After conclusion of the program on June 17, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet for a unit program consisting of a Unit (shares of stock and warrants) to a participant. After conclusion of the program on May 28, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant has the company notation of “ZNWAP.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 2, 2021 and continue to be exercisable through June 2, 2022 at a per share exercise price of $.25.

 

On March 21, 2022, the Company extended the termination date of the ZNWAP Warrant by one (1) year from the expiration date of June 2, 2022 to June 2, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAQ.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued on May 5, 2022 and were exercisable through July 15, 2023 at a revised per share exercise price of $.05.

 

Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On June 16, 2023, the Company extended the termination date of the ZNWAQ warrant from July 15, 2023 to September 6, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On August 21, 2023, the Company extended the termination date of the ZNWAQ warrant from September 6, 2023 to October 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On October 19, 2023, the Company extended the termination date of the ZNWAQ warrant from October 31, 2023 to December 31, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On December 18, 2023, the Company extended the termination date of the ZNWAQ warrant from December 31, 2023 to March 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

On March 28, 2024, the Company extended the termination date of the ZNWAQ warrant from March 31, 2024 to December 31, 2024. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension. 

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on June 18, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAR.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants were issued and became exercisable on June 22, 2021 and continued to be exercisable through June 22, 2022 at a per share exercise price of $.25. Additionally, Zion incurred $115,000 during 2021 in equity issuance costs to an outside party related to this waiver program.

 

On March 21, 2022, the Company extended the termination date of the ZNWAR Warrant by one (1) year from the expiration date of June 22, 2022 to June 22, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

During the second quarter of 2022, all warrants represented by ZNWAP and ZNWAR were exercised resulting in a net cash inflow of approximately $365,000.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on November 15, 2021, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and warrants that will be acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $1.00. The warrant shall have the company notation of “ZNWAS.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a revised per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on September 30, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAT.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and become exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a unit program consisting of units of shares of stock and warrants to a participant. After conclusion of the program on December 31, 2022, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $.25. The warrant shall have the company notation of “ZNWAU.” The warrants will not be registered for trading on the OTCQB or any other stock market or trading market. The warrants will be issued and exercisable on November 15, 2025 and continue to be exercisable through December 31, 2025 at a per share exercise price of $.25.

 

Under our Plan, the Company under a Request For Waiver Program executed a Waiver Term Sheet of a program consisting of shares of stock to a participant. After conclusion of the program on August 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. Zion incurred $173,000 in equity issuance costs to an outside party related to this waiver program. The Company executed two additional Waiver Term Sheets with a participant consisting of shares of stock. After conclusion of the program on December 31, 2023, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired. During the year ended December 31, 2023, Zion incurred $1,120,000 in equity issuance costs.

 

On January 1, 2024, the Company executed a Waiver Term Sheet with a participant consisting of shares of stock. After conclusion of the program on March 31, 2024, the participant’s Plan account was credited with the number of shares of the Company’s Common Stock that were acquired.

 

During the three and nine months ended September 30, 2024, Zion incurred $536,000 and $2,299,000 in equity issuance costs. During the three and nine months ended September 30, 2023, Zion incurred $437,000 and $610,000 in equity issuance costs. 

 

On April 1, 2024, the Company executed its current Waiver Term Sheet with a participant consisting of shares of stock and warrants. On or around September 30, 2024, a second amendment to this latest Waiver Term Sheet was signed with the participant. The program terminates at the earlier of: (a) a maximum purchase of $10,000,000 through the DSPP, (b) December 31, 2024 or (c) the closing price of Zion’s stock is 15 cents per share for five (5) consecutive days. Additional terms of the Waiver Term Sheet include the pro-rata issuance of up to 10,000,000 warrants with an exercise price of $.25 per share and an expiration date of April 1, 2025, in the event the Participant purchases up to $10,000,000 of the Company’s stock by December 31, 2024.

 

During 2024, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 65% of the net cash raised through the DSPP. 

 

During 2023, one participant who participated in the “Request for Waiver” aspect of the DSPP contributed approximately 54% of the net cash raised through the DSPP.

 

On March 13, 2023, Zion filed with the Securities and Exchange Commission an Amendment No. 2 to the Prospectus Supplement dated as of December 15, 2021 and accompanying base prospectus dated December 1, 2021 relating to the Company’s Dividend Reinvestment and Direct Stock Purchase Plan. The Prospectus forms a part of the Company’s Registration Statement on Form S-3 (File No. 333-261452), as amended, which was declared effective by the SEC on December 15, 2021.

 

Amendment No. 2 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 2. Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 2 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option had up to three tranches of investment, in which the second and third tranches were each subject to termination upon a total of $7,500,000 received from participants by the Company during the first or second tranche. The first tranche period began on March 13, 2023 and terminated on March 26, 2023. The second tranche began on March 27, 2023 and terminated on April 9, 2023 and the third tranche began on April 10, 2023 and terminated on April 27, 2023.

 

The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional five hundred (500) shares of Common Stock at a per share exercise price of $0.05. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.05. The warrant shall have the Company notation of “ZNWAV” under the first tranche, “ZNWAW” under the second tranche and “ZNWAX” under the third tranche.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.05 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and shall have the Company notation of “ZNWAY.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program. Plan participants, who enrolled in the AMI at a minimum of $100 per month, received one hundred (100) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $250 per month, received two hundred and fifty (250) ZNWAY warrants. Plan participants, who enrolled in the AMI at a minimum of $500 per month, received five hundred (500) ZNWAY warrants. The AMI program required 90 days of participation to receive the ZNWAY warrants. Existing AMI participants were entitled to participate in this monthly program by increasing their monthly amount above the minimum $50.00 per month.

 

The ZNWAV warrants became exercisable on March 31, 2023 and continued to be exercisable through June 28, 2023 at a per share exercise price of $0.05.

 

As of June 28, 2023, any outstanding ZNWAV warrants expired.

 

The ZNWAW warrants became exercisable on April 14, 2023 and continued to be exercisable through July 13, 2023 at a per share exercise price of $0.05.

 

As of July 13, 2023, any outstanding ZNWAW warrants expired.

 

The ZNWAX warrants became exercisable on May 2, 2023 and continued to be exercisable through July 31, 2023 at a per share exercise price of $0.05.

 

On July 31, 2023, any outstanding ZNWAX warrants expired.

 

The ZNWAY warrants became exercisable on June 12, 2023 and continued to be exercisable through September 10, 2023 at a per share exercise price of $0.05.

 

On September 10, 2023, any outstanding ZNWAY warrants expired.

 

Amendment No. 3 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under Amendment No. 3. This Unit Option period began on May 15, 2023 and terminated on June 15, 2023.

 

Our Unit Program consisted of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1 and Amendment No.2. Amendment No. 3 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. As mentioned above, this Unit Option began on May 15, 2023 and terminated on June 15, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional two hundred (200) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account was credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWAZ” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enrolled in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional three hundred (300) warrants at an exercise price of $0.25 during this Unit Option Program. The three hundred (300) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWAZ.” Existing subscribers to the AMI were entitled to the additional three hundred (300) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWAZ warrants became exercisable on July 17, 2023 and continued to be exercisable through July 17, 2024 at a per share exercise price of $0.25.

 

On July 17, 2024, any outstanding ZNWAZ warranted expired.

 

Amendment No. 4 – New Unit Option under the Unit Program

 

Under our Plan, we provided a Unit Option under our Unit Program with this Amendment No. 4. This Unit Option period began on November 6, 2023 and was scheduled to terminate on December 31, 2023. See Amendment No. 5 below for data on an extension.

 

Our Unit Program consists of the combination of Common Stock and warrants with basic Unit Program features, conditions and terms outlined in the Original Prospectus Supplement and Amendment No. 1. Amendment No. 4 provided the option period, unit price and the determination of the number of shares of Common Stock and warrants per unit. This Unit Option began on November 6, 2023 and terminated on December 31, 2023. The Unit Option consisted of Units of our securities where each Unit (priced at $250.00 each) was comprised of (i) a certain number of shares of Common Stock determined by dividing $250.00 (the price of one Unit) by the average of the high and low sale prices of the Company’s publicly traded common stock as reported on the OTCQB on the Unit Purchase Date and (ii) Common Stock purchase warrants to purchase an additional fifty (50) shares of Common Stock at a per share exercise price of $0.25. The participant’s Plan account will be credited with the number of shares of the Company’s Common Stock and Warrants that were acquired under the Units purchased. Each warrant affords the participant the opportunity to purchase one share of our Common Stock at a warrant exercise price of $0.25. The warrant shall have the Company notation of “ZNWBA” and will not be registered for trading on the OTCQB or any other stock market or trading market.

 

Plan participants, who enrolled into the Unit Program with the purchase of at least one Unit and enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month, received an additional fifty (50) warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants were for enrolling into the AMI program and received the above warrant with the Company notation of “ZNWBA.” Existing subscribers to the AMI were entitled to the additional fifty (50) warrants, if they purchased at least one (1) Unit during the Unit program.

 

The ZNWBA warrants became exercisable on January 15, 2024, and continue to be exercisable through January 15, 2025, unless extended, at a per share exercise price of $0.25. See Amendment No. 5 below for new dates.

 

Amendment No. 5 – Extension of Termination Date to January 31, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consisted of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate December 31, 2023, but now was scheduled to terminate on January 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enrolled into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on February 15, 2024, instead of January 15, 2024, and continue to be exercisable through February 15, 2025, instead of January 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.

 

The date of this Amendment No. 5 to Prospectus Supplement was December 20, 2023.

 

Amendment No. 6 – Extension of Termination Date to February 29, 2024

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended the Unit Program that was to terminate January 31, 2024, but now was scheduled to terminate February 29, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on March 15, 2024, instead of February 15, 2024, and continue to be exercisable through March 15, 2025, instead of February 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 6 to Prospectus Supplement was January 29, 2024.

  

Amendment No. 7 – Extension of Termination Date to March 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate February 29, 2024, but now will terminate March 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on April 15, 2024, instead of March 15, 2024, and continue to be exercisable through April 15, 2025, instead of March 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 7 to Prospectus Supplement was February 26, 2024.

 

Amendment No. 8 – Extension of Termination Date to April 30, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate March 31, 2024, but now will terminate April 30, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on May 15, 2024, instead of April 15, 2024, and continue to be exercisable through May 15, 2025, instead of April 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 8 to Prospectus Supplement was March 23, 2024.

 

Amendment No. 9 – Extension of Termination Date to May 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate April 30, 2024, but now will terminate May 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on June 15, 2024, instead of May 15, 2024, and continue to be exercisable through June 15, 2025, instead of May 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 9 to Prospectus Supplement was April 24, 2024.

 

Amendment No. 10 – Extension of Termination Date to August 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate May 31, 2024, but now will terminate August 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on September 15, 2024, instead of June 15, 2024, and continue to be exercisable through September 14, 2025, instead of June 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 10 to Prospectus Supplement was May 29, 2024.

 

Amendment No. 11 – Extension of Termination Date to October 15, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate August 31, 2024, but now will terminate October 15, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on November 15, 2024, instead of September 15, 2024, and continue to be exercisable through November 14, 2025, instead of September 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

The date of this Amendment No. 11 to Prospectus Supplement was August 22, 2024.

 

Amendment No. 12 – Extension of Termination Date to December 31, 2024  

 

Under our Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), we extended the current Unit Option that was filed under Amendment No. 4, dated November 6, 2023. Our Unit Program consists of the combination of Common Stock and warrants with an extended time period, but otherwise the same Unit Program features, conditions and terms in the Prospectus Supplement and Amendment No. 4 apply.  We extended under our Unit Program that was to terminate October 15, 2024, but now will terminate December 31, 2024, and we extended the exercise and termination dates of the related ZNWBA warrants.

 

For Plan participants who enroll into the Unit Program with the purchase of at least one Unit and also enroll in the separate Automatic Monthly Investments (“AMI”) program at a minimum of $50.00 per month or more, will receive an additional fifty (50) Warrants at an exercise price of $0.25 during this Unit Option Program. The fifty (50) additional warrants are for enrolling into the AMI program. Existing subscribers to the AMI are entitled to the additional fifty (50) warrants once, if they purchase at least one (1) Unit during the Unit program.

 

The ZNWBA warrants will be first exercisable on January 31, 2025, instead of November 15, 2024, and continue to be exercisable through January 31, 2026, instead of November 15, 2025, unless extended, at a per share exercise price of $0.25. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

Accordingly, all references in the Original Prospectus Supplement and Amendment No. 1 and Amendment No. 4, concerning the Unit Option, continue, except for the substitution of the revised Unit Option dates and features above. All other Plan features, conditions and terms remain unchanged.  

 

The date of this Amendment No. 12 to Prospectus Supplement was October 9, 2024.

 

For the three and nine months ended September 30, 2024, approximately $3,692,000 and $12,160,000 were raised under the DSPP program, respectively. The $3,692,000 and $12,160,000 figures were reduced by $536,000 and $2,299,000, respectively, in equity issuance costs to an outside party resulting in net cash provided of $3,156,000 and $9,861,000, respectively.

 

For the three and nine months ended September 30, 2023, approximately $1,805,000, and $4,358,000 were raised under the DSPP program, respectively. The $1,805,000 and $4,358,000 figures are net of $437,000 and $610,000 in equity issuance costs to an outside party, respectively.

 

The company raised approximately $1,319,000 from the period October 1, 2024 through November 6, 2024, under the DSPP program.

 

The warrants represented by the company notation ZNWAA are tradeable on the OTCQB market under the symbol ZNOGW. However, all of the other warrants characterized above, in the table below, and throughout this Form 10-Q, are not tradeable and are used internally for classification and accounting purposes only.

 

E. Subscription Rights Offering   

 

On April 2, 2018 the Company announced an offering (“2018 Subscription Rights Offering”) through American Stock Transfer & Trust Company, LLC (the “Subscription Agent”), at no cost to the shareholders, of non-transferable Subscription Rights (each “Right” and collectively, the “Rights”) to purchase its securities to persons who owned shares of our Common Stock on April 13, 2018 (“the Record Date”). Pursuant to the 2018 Subscription Rights Offering, each holder of shares of common stock on the Record Date received non-transferable Subscription Rights, with each Right comprised of one share of the Company Common Stock, par value $0.01 per share (the “Common Stock”) and one Common Stock Purchase Warrant to purchase an additional one share of Common Stock. Each Right could be exercised or subscribed at a per Right subscription price of $5.00. Each Warrant affords the investor the opportunity to purchase one share of the Company Common Stock at a warrant exercise price of $3.00. The warrant is referred to as “ZNWAI.”

 

The warrants became exercisable on June 29, 2018 and continued to be exercisable through June 29, 2020 at a per share exercise price of $3.00, after the Company, on December 4, 2018, extended the termination date of the Warrant by one (1) year from the expiration date of June 29, 2019 to June 29, 2020.

 

On May 29, 2019, the Company extended the termination date of the ZNWAI Warrant by one (1) year from the expiration date of June 29, 2020 to June 29, 2021.

 

On September 15, 2020, the Company extended the termination date of the ZNWAI Warrant by two (2) years from the expiration date of June 29, 2021 to June 29, 2023. Zion considers this warrant as permanent equity per ASC 815-40-35-2. As such, there is no value assigned to this extension.

 

As of June 29, 2023, any outstanding ZNWAI warrants expired.

 

Each shareholder received .10 (one tenth) of a Subscription Right (i.e. one Subscription Right for each 10 shares owned) for each share of the Company’s Common Stock owned on the Record Date.

 

The 2018 Subscription Rights Offering terminated on May 31, 2018. The Company raised net proceeds of approximately $3,038,000, from the subscription of Rights, after deducting fees and expenses of $243,000 incurred in connection with the rights offering.

 

F. Warrant Table  

 

The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:

 

Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
09/30/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
      -
    
       -
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    (153,800)   
-
 
Outstanding warrants           29,697,020    
-
    
-
    (393,868)   29,303,152 

 

G. Warrant Descriptions of Current Warrants

 

The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with a future expiration date.

 

      Period of Grant   US$   Expiration Date
ZNWAA Warrants  A,B,E,H   March 2013 – December 2014    2.00   January 31, 2025
ZNWAM Warrants  C,F,I,J   January 2021 – March 2021    0.05   December 31, 2024
ZNWAQ Warrants  C,F,I,J   June 2021    0.05   December 31, 2024
ZNWAS Warrants  D   August 2021 – March 2022    0.25   December 31, 2025
ZNWAT Warrants  D   August – September 2022    0.25   December 31, 2025
ZNWAU Warrants  D   October – November 2022    0.25   December 31, 2025
ZNWBA Warrants  G,K   November – December 2024    0.25   January 31, 2026

 

A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.

 

H On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.

 

I On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.

 

J On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
   
K

On May 29, 2024, the Company filed Amendment No. 10 whereby the current unit option was extended to August 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On August 22, 2024, the Company filed Amendment No. 11 whereby the current unit option was extended to October 15, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended.  On October 9, 2024, the Company filed Amendment No. 12 whereby the current unit option was extended to December 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended to January 31, 2026.

v3.24.3
Unproved Oil and Gas Properties, Full Cost Method
9 Months Ended
Sep. 30, 2024
Unproved Oil and Gas Properties, Full Cost Method [Abstract]  
Unproved Oil and Gas Properties, Full Cost Method

Note 4 - Unproved Oil and Gas Properties, Full Cost Method

 

Unproved oil and gas properties, under the full cost method, are comprised as follows:

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   6,050    2,538 
Capitalized salary costs   2,521    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,005    10,198 
Other costs   39    39 
    21,033    16,637 

 

Post Impairment of unproved oil and gas properties comprised as follows:

 

   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   
     -
    20    
     -
    76 
Capitalized salary costs   
-
    
-
    
-
    
-
 
Capitalized interest costs   
-
    
-
    
-
    
-
 
Legal costs, license fees and other preparation costs   
-
    16    
-
    53 
Other costs   
-
    
-
    
-
    
-
 
    
-
    36    
-
    129 

 

Changes in Unproved oil and gas properties during the three and nine months ended September 30, 2024 and 2023 are as follows:

 

   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   2,865    58    3,512    204 
Capitalized salary costs   26    25    77    77 
Capitalized interest costs   
-
    
-
    -    - 
Legal and seismic costs, license fees and other preparation costs   327    103    807    301 
Other costs   
-
    
-
    -    - 
Impairment of unproved oil and gas properties   
-
    (36)   -    (129)
    *3,218    *150    *4,396    *453 

  

* Inclusive of non-cash amounts of approximately $146,000, and $129,000 during the three months ended September 30, 2024, and 2023, respectively
   
* Inclusive of non-cash amounts of approximately $856,000, and $677,000 during the nine months ended September 30, 2024, and 2023, respectively

 

Please refer to Footnote 1 – Nature of Operations and Going Concern for more information about Zion’s exploration activities.

v3.24.3
Right of Use Lease Assets and Lease Obligations
9 Months Ended
Sep. 30, 2024
Right of Use Lease Assets and Lease Obligations [Abstract]  
Right of use lease assets and lease obligations

Note 5 - Right of use lease assets and lease obligations  

 

The Company is a lessee in several non-cancellable operating leases for transportation and office space.

 

The table below presents the operating lease assets and liabilities recognized on the balance sheet as of September 30, 2024 and December 31, 2023:

 

   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $826   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $145   $167 
Non-current operating lease liabilities  $652   $24 
Total operating lease liabilities  $797   $191 

 

The depreciable lives of operating lease assets and leasehold improvements are limited by the expected lease term.

 

The Company’s leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular currency environment. The Company used incremental borrowing rates as of January 1, 2019 for operating leases that commenced prior to that date.

 

The Company’s field office in Caesarea, Israel is under lease for 6,566 square feet.

 

The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,500) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.

 

The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of September 30, 2024 are:

 

   September 30,
2024
 
Weighted average remaining lease term (years)   5.9 
Weighted average discount rate   7.8%

 

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of September 30, 2024:

 

    US$
thousands
 
2024    49 
2025    155 
2026    151 
2027    149 
2028    149 
Thereafter    346 
Total undiscounted future minimum lease payments    999 
Less: portion representing imputed interest    (202)
Total undiscounted future minimum lease payments    797 

 

Operating lease costs were $75,000 and $224,000 for the three and nine months ended September 30, 2024, respectively.

 

Operating lease costs were $76,000 and $203,000 for the three and nine months ended September 30, 2023, respectively. Operating lease costs are included within general and administrative expenses on the statements of operations.

 

Cash paid for amounts included in the measurement of operating lease liabilities was $55,000 and $223,000 for the three and nine months ended September 30, 2024, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was $76,000 and $203,000 for the three and nine months ended September 30, 2023, respectively These amounts are included in operating activities in the statements of cash flows.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $nil and $829,000 for the three and nine months ended September 30, 2024, respectively.

 

Right-of-use assets obtained in exchange for new operating lease liabilities were $252,000 and $252,000 for the three and nine months ended September 30, 2023, respectively.

v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

Note 6 - Commitments and Contingencies

 

A. Litigation

 

From time to time, the Company may be subject to routine litigation, claims or disputes in the ordinary course of business. The Company defends itself vigorously in all such matters. However, we cannot predict the outcome or effect of any of the potential litigation, claims or disputes. 

 

The Company is not subject to any litigation at the present time. 

 

B. Market Conditions – Coronavirus, Israel-Hamas War, the Israel-Hezbollah War and Russia-Ukraine War

 

Coronavirus

 

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

 

Israel-Hamas War

 

On October 7, 2023, Hamas, a militant terrorist organization in Gaza, infiltrated southern Israel, killing and injuring at least one thousand Israeli citizens. Roughly 250 Israeli hostages were then taken back to Gaza. This unprovoked attack led the nation of Israel to declare war on Hamas approximately one week later. As of the date of this report, Israel remains at war and there are daily battles inside the Gaza strip. Israel’s stated goals are to completely dismantle the terror infrastructure of Gaza, including its extensive tunnel network and to bring back safely all of the hostages.

 

Israel-Hezbollah War and Wider Hostilities

 

Immediately after the October 7, 2023 Hamas attack on Israel, the terrorist organization Hezbollah (in Lebanon) began launching daily rockets into Israel. Over the course of the next several months, both Hezbollah and Israel traded rocket fire into the other country, but without engaging in a full war. During Q3 2024, both sides increased the frequency and number of missiles fired. In September 2024, Israel began a ground invasion into Lebanon and both sides are at war today. As a result of the wars in Israel, most airlines are not flying in and out of Israel, and the ports in Haifa and Ashdod remain closed.

 

Russia-Ukraine War

 

Due to Russia’s invasion of Ukraine, which began in February 2022, and the resulting sanctions and other actions against Russia and Belarus, there has been uncertainty and disruption in the global economy. Although the Russian war against Ukraine did not have a material adverse impact on the Company’s financial results for the quarter ended September 30, 2024, at this time the Company is unable to fully assess the aggregate impact the Russian war against Ukraine will have on its business due to various uncertainties, which include, but are not limited to, the duration of the war, the war’s effect on the global economy, future energy pricing, its impact to the businesses of the Company and actions that may be taken by governmental authorities related to the war.

 

C. Environmental and Onshore Licensing Regulatory Matters   

 

The Company is engaged in oil and gas exploration and production and may become subject to certain liabilities as they relate to environmental clean-up of well sites or other environmental restoration procedures and other obligations as they relate to the drilling of oil and gas wells or the operation thereof. Various guidelines have been published in Israel by the State of Israel’s Petroleum Commissioner and Energy and Environmental Ministries as it pertains to oil and gas activities. Mention of these older guidelines was included in previous Zion filings. 

 

The Company believes that these regulations will result in an increase in the expenditures associated with obtaining new exploration rights and drilling new wells. The Company expects that an additional financial burden could occur as a result of requiring cash reserves that could otherwise be used for operational purposes. In addition, these regulations are likely to continue to increase the time needed to obtain all of the necessary authorizations and approvals to drill and production test exploration wells.

 

As of September 30, 2024, and December 31, 2023, the Company accrued $nil and $nil for license regulatory matters.

 

D. Insurance Financing

 

Effective November 16, 2023, the Company renewed its third-party liability (“TPL”) insurance policy in Israel with total premiums, taxes and fees for $76,263. A cash down payment of $22,699 was paid on November 16, 2023. Under the terms of the insurance financing, payments of $5,356, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on December 16, 2023. The Company has completed its financing commitment pertaining to the TPL insurance as of September 30, 2024.

 

Effective December 28, 2023, the Company renewed its D&O insurance policy with total premiums, taxes and fees for $441,598. A cash down payment of $68,733 was paid on December 13, 2023. Under the terms of the insurance financing, payments of $37,287, which include interest at the rate of 13.4% per annum, are due each month for 10 months commencing on January 28, 2024.

 

Effective March 12, 2024, 2024, the Company renewed its rig insurance policy with total premiums, taxes and fees for $94,989. A cash down payment of $37,637 was paid on February 23, 2024. Under the terms of the insurance financing, payments of $9,499, which include interest at the rate of 13.99% per annum, are due each month for 10 months commencing on April 12, 2024.

 

As of September 30, 2024 and December 31, 2023, the Company had contractual obligations to pay for various lines of insurance, including directors and officers, rig and third-party liability. The balances for insurance financing were $75,000 and $432,000, respectively.

 

We haven’t experienced any resistance from our insurance carriers as a result of the Israel-Hamas war or Israel-Hezbollah war, but we acknowledge the uncertainties that the war(s) creates in that respect. 

 

E. Bank Guarantees

 

As of September 30, 2024, the Company provided Israeli-required bank guarantees to various governmental bodies (approximately $971,000) and others (approximately $91,000) with respect to its drilling operation in an aggregate amount of approximately $1,062,000. The (cash) funds backing these guarantees are held in restricted interest-bearing accounts in Israel and are reported on the Company’s balance sheets as fixed short-term bank deposits – restricted.

 

F. Vendor Concentration

 

The Company’s financial instruments that are exposed to a concentration of credit risk are accounts payable. At September 30, 2024, there were two suppliers that represent 10% or more of the Company’s accounts payable balance. At December 31, 2023, there were three suppliers that represent 10% or more of the Company’s accounts payable balance.

 

G. Risks

 

Market risk is a broad term for the risk of economic loss due to adverse changes in the fair value of a financial instrument. These changes may be the result of various factors, including interest rates, foreign exchange rates, commodity prices and/or equity prices. In the normal course of doing business, we are exposed to the risks associated with foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Rate Risks. A portion of our expenses, primarily labor expenses and certain supplier contracts, are denominated in New Israeli Shekels (“NIS”). As a result, we have significant exposure to the risk of fluctuating exchange rates with the U.S. Dollar (“USD”), our primary reporting currency. During the period January 1, 2024 through September 30, 2024, the USD has fluctuated by approximately 2.3% against the NIS (the USD strengthened relative to the NIS). Also, during the period January 1, 2023 through December 31, 2023, the USD fluctuated by approximately 3.1% against the NIS (the USD strengthened relative to the NIS). Continued strengthening of the US dollar against the NIS will result in lower operating costs from NIS denominated expenses. To date, we have not hedged any of our currency exchange rate risks, but we may do so in the future.

 

Interest Rate Risk. Our exposure to market risk relates to our cash and investments. We maintain an investment portfolio of short-term bank deposits and money market funds. The securities in our investment portfolio are not leveraged, and are, due to their very short-term nature, subject to minimal interest rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our investments, we do not believe that a change in market interest rates would have a significant negative impact on the value of our investment portfolio except for reduced income in a low interest rate environment. At September 30, 2024, we had cash, cash equivalents and short-term bank deposits of approximately $1,847,000. The weighted average annual interest rate related to our cash and cash equivalents for the three and nine months ended September 30, 2024, exclusive of funds at US banks that earn no interest, was approximately 2.8% and 2.9%, respectively.

 

The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest our excess cash in short-term bank deposits and money market funds that may invest in high quality debt instruments.

v3.24.3
Subsequent Events
9 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events

Note 7 - Subsequent Events

 

The Company has evaluated subsequent events through November 7, 2024, the date of filing of this Quarterly Report on Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements, other than the following:

 

(i) Approximately $1,319,000 was collected through the Company’s DSPP program during the period October 1 through November 6, 2024.

v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (1,791) $ (1,743) $ (5,617) $ (6,216)
v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Net Loss per Share Data

A. Net Loss per Share Data 

Basic and diluted net loss per share of common stock, par value $0.01 per share (“Common Stock”) is presented in conformity with ASC 260-10 “Earnings Per Share.” Diluted net loss per share is the same as basic net loss per share for 2024 as the inclusion of 33,337,132 in stock options and 29,303,152 in warrants would be anti-dilutive.

Diluted net loss per share is the same as basic net loss per share for 2023 as the inclusion of 27,096,250 in stock options and 30,242,620 in warrants would be anti-dilutive.

Use of Estimates

B. Use of Estimates 

The preparation of the accompanying unaudited consolidated condensed financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of expenses. Such estimates include the valuation of unproved oil and gas properties, deferred tax assets, asset retirement obligations, borrowing rate of interest consideration for leases, accounting and legal contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Illiquid credit markets, volatile equity, foreign currency, political instability and energy markets have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated condensed financial statements in future periods.

During March 2020, a global pandemic was declared by the World Health Organization related to the rapidly growing outbreak of a novel strain of coronavirus (“COVID-19”). The pandemic significantly impacted the economic conditions in the United States and Israel, as federal, state and local governments reacted to the public health crisis, creating significant uncertainties in the United States, Israel and world economies. In the interest of public health and safety, jurisdictions (international, national, state and local) where we have operations, restricted travel and required workforces to work from home. However, as of the date of this report, most of our employees are working at our physical offices, but have the ability to work from home as needed.

Similar uncertainties are posed by the Israel-Hamas war, as well as the Israel-Lebanon war. The duration of both wars and its impact on the region and world is not fully known at this point in time. As stated previously in this report, our operations are paused and our rig crew workers are safely out of Israel and at home.

Actual results may differ from these estimates.

Oil and Gas Properties and Impairment

C. Oil and Gas Properties and Impairment 

The Company follows the full-cost method of accounting for oil and gas properties. Accordingly, all costs associated with acquisition, exploration and development of oil and gas reserves, including directly related overhead costs, are capitalized.

All capitalized costs of oil and gas properties, including the estimated future costs to develop proved reserves, are amortized on the unit-of-production method using estimates of proved reserves. Investments in unproved properties and major development projects are not amortized until proved reserves associated with the projects can be determined or until impairment occurs. If the results of an assessment indicate that the properties are impaired, the amount of the impairment is included in loss from continuing operations before income taxes, and the adjusted carrying amount of the proved properties is amortized on the unit-of-production method.

 

The Company’s oil and gas property represents an investment in unproved properties. These costs are excluded from the amortized cost pool until proved reserves are found or until it is determined that the costs are impaired. All costs excluded are reviewed at least quarterly to determine if impairment has occurred. The amount of any impairment is charged to expense since a reserve base has not yet been established. Impairment requiring a charge to expense may be indicated through evaluation of drilling results, relinquishing drilling rights or other information.

During the three and nine months ended September 30, 2024, the Company did not record any post-impairment charges.

During the three and nine months ended September 30, 2023, the Company recorded post-impairment charges of $36,000 and $129,000, respectively.

Currently, the Company has no economically recoverable reserves and no amortization base. The Company’s unproved oil and gas properties consist of capitalized exploration costs of $21,033,000 and $16,637,000 as of September 30, 2024 and December 31, 2023, respectively.

Fair Value Measurements

D. Fair Value Measurements 

The Company follows Accounting Standards Codification (ASC) 820, “Fair Value Measurements and Disclosures,” as amended by Financial Accounting Standards Board (FASB) Financial Staff Position (FSP) No. 157 and related guidance. Those provisions relate to the Company’s financial assets and liabilities carried at fair value and the fair value disclosures related to financial assets and liabilities. ASC 820 defines fair value, expands related disclosure requirements, and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, assuming the transaction occurs in the principal or most advantageous market for that asset or liability.

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;
  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and
  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

The Company’s financial instruments, including cash and cash equivalents, other receivables. accounts payable and accrued liabilities, are carried at historical cost. At September 30, 2024, and December 31, 2023, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.  

 

Stock-Based Compensation

E. Stock-Based Compensation 

ASC 718, “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated condensed financial statements based on their fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “Equity – Based Payments to Non-Employees.” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Warrants

F. Warrants 

In connection with the Dividend Reinvestment and Stock Purchase Plan (“DSPP”) financing arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are stand-alone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded and accounted as a part of the DSPP investment as additional paid-in capital of the common stock issued. All other warrants are recorded at fair value and expensed over the requisite service period or at the date of issuance, if there is not a service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 3, Stockholders’ Equity.

Related parties

G. Related parties 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. All transactions with related parties are recorded at fair value of the goods or services exchanged.

Zion did not have any related party transactions for the periods covered in this report.

 

Recently Adopted Accounting Pronouncements

H. Recently Adopted Accounting Pronouncements   

The Company does not believe that the adoption of any recently issued accounting pronouncements in 2024 had a significant impact on our consolidated condensed financial position, results of operations, or cash flow.

Depreciation and Accounting for Drilling Rig and Related Equipment

I. Depreciation and Accounting for Drilling Rig and Related Equipment

On March 12, 2020, Zion purchased an onshore oil and gas drilling rig, drilling pipe, related equipment and spare parts for a purchase price of $5.6 million in cash, inclusive of approximately $540,000 allocated in spare parts and $48,000 allocated in additional separate assets. The value of the spare parts and separate assets are captured in separate ledger accounts, but reported as one line item with the drilling rig on the balance sheet. Zion determined that the life of the I-35 drilling rig (the rig Zion purchased), is 10 years. Zion is depreciating the rig on a straight-line basis.

Zion uses the First In First Out (“FIFO”) method of accounting for the spare parts, meaning that the earliest items purchased will be the first item charged to the well in which the spare parts gets consumed.

It is also noteworthy that various components and systems on the rig will be subject to certifications by the manufacturer to ensure that the rig is maintained at optimal levels. Per standard practice in upstream oil and gas, each certification performed on our drilling rig increases the useful life of the rig by five years. The costs of each certification will be added to the drilling rig account, and our straight-line amortization will be adjusted accordingly.

Zion purchased rig spare parts totaling approximately $178,000 during the year 2024 in preparation for its MJ-01 re-entry project.

Zion sold some excess scrap drilling pipe and accessories for approximately $35,000 to a local Israeli party during the year 2024. This transaction triggered a reduction in Other Drilling Assets, an accumulated depreciation adjustment and a loss on the disposal.

See the table below for a reconciliation of the rig-related activity during the period ended September 30, 2024:

I-35 Drilling Rig & Associated Equipment:

   Nine-months ended September 30, 2024 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    178    
-
    178 
Asset Depreciation   (476)   
-
    (118)   (594)
Asset Disposals   
-
    
-
    (97)   (97)
Asset Disposals for Self-Consumption   
-
    (39)   
-
    (39)
September 30, 2024   4,115    747    96    4,958 

 

   As of December 31, 2023 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2022   5,225    619    437    6,281 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (634)   
-
    (117)   (751)
Asset Disposals for Self-Consumption   
-
    (11)   
-
    (11)
December 31, 2023   4,591    608    311    5,510 
v3.24.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Drilling Rig & Associated Equipment See the table below for a reconciliation of the rig-related activity during the period ended September 30, 2024:
   Nine-months ended September 30, 2024 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
December 31, 2023   4,591    608    311    5,510 
Asset Additions   
-
    178    
-
    178 
Asset Depreciation   (476)   
-
    (118)   (594)
Asset Disposals   
-
    
-
    (97)   (97)
Asset Disposals for Self-Consumption   
-
    (39)   
-
    (39)
September 30, 2024   4,115    747    96    4,958 

 

   As of December 31, 2023 
   I-35
Drilling
Rig
   Rig
Spare
Parts
   Other
Drilling
Assets
   Total 
   US$ thousands   US$ thousands   US$ thousands   US$ thousands 
December 31, 2022   5,225    619    437    6,281 
Asset Additions   
-
    
-
    
-
    
-
 
Asset Depreciation   (634)   
-
    (117)   (751)
Asset Disposals for Self-Consumption   
-
    (11)   
-
    (11)
December 31, 2023   4,591    608    311    5,510 
v3.24.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Stock Option Transactions The stock option transactions since January 1, 2024 are shown in the table below:
   Number of
shares
   Weighted
Average
exercise
price
 
       US$ 
Outstanding, December 31, 2023   34,091,250    0.23 
           
Changes during 2024 to:          
Granted to employees, officers, directors and others   210,000    0.07 
Expired/Cancelled/Forfeited   (825,943)   1.72 
Exercised   (138,175)   0.07 
Outstanding, September 30, 2024   33,337,132    0.19 
Exercisable, September 30, 2024   33,337,132    0.19 

 

Schedule of Stock Options Outstanding The following table summarizes information about stock options outstanding as of September 30, 2024:
Shares underlying outstanding options (non-vested)     Shares underlying outstanding options (fully vested)  
Range of
exercise
price
    Number
outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
    Range of
exercise
price
    Number
Outstanding
    Weighted
average
remaining
contractual
life (years)
    Weighted
Average
Exercise
price
 
US$                 US$     US$                 US$  
                          0.01       107,500       2.25       0.01  
                          0.01       50,000       2.26       0.01  
                          0.01       60,000       2.55       0.01  
                          0.01       200,000       3.64       0.01  
                          0.01       40,000       3.00       0.01  
                          0.01       70,000       3.25       0.01  
                          0.01       25,000       3.26       0.01  
                          0.01       30,000       3.41       0.01  
                          0.01       4,000       3.52       0.01  
                          0.01       25,000       4.27       0.01  
                          0.01       35,000       5.97       0.01  
                          0.01       150,000       5.14       0.01  
                          0.01       35,000       4.97       0.01  
                          0.01       75,000       6.27       0.01  
                          0.01       200,000       6.64       0.01  
                          0.01       300,000       6.80       0.01  
                          0.01       10,000       6.92       0.01  
                          0.01       500,000       7.27       0.01  
                          0.01       55,000       7.30       0.01  
                          0.01       960,000       7.55       0.01  
                          0.01       75,000       7.87       0.01  
                          0.01       10,000       7.93       0.01  
                          0.01       795,000       7.99       0.01  
                          0.01       25,000       8.27       0.01  
                          0.01       10,000       8.93       0.01  
                          0.01       895,000       8.98       0.01  
                          0.01       25,000       9.27       0.01  
                          0.01       10,000       9.93       0.01  
                          0.06       50,000       8.27       0.06  
                          0.07       125,000       9.27       0.07  
                          0.07       6,980,000       8.99       0.07  
                          0.14       210,000       7.30       0.14  
                          0.15       3,200,000       7.27       0.15  
                          0.15       6,354,325       7.55       0.15  
                          0.16       340,000       1.19       0.16  
                          0.16       75,000       5.20       0.16  
                          0.18       25,000       1.17       0.18  
                          0.18       5,130,000       7.99       0.18  
                          0.24       25,000       7.84       0.24  
                          0.24       118,000       7.87       0.24  
                          0.25       50,000       6.92       0.25  
                          0.25       363,000       6.92       0.25  
                          0.28       25,000       0.93       0.28  
                          0.28       25,000       4.93       0.28  
                          0.29       25,000       2.71       0.29  
                          0.39       1,435,000       6.78       0.39  
                          0.59       1,400,000       2.64       0.59  
                          0.59       1,600,000       6.64       0.59  
                          0.92       350,000       2.26       0.92  
                          0.92       550,000       6.27       0.92  
                          1.38       105,307       0.26       1.38  
                              0.01-1.38       33,337,132               0.19  

 

Schedule of Weighted-Average Fair Value of Options Granted The following table sets forth information about the weighted-average fair value of options granted to employees and directors during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date  $0.07   $0.07 
Dividend yields   
    
 
Expected volatility   133%-134%   135%-137%
Risk-free interest rates   3.71%-3.97%   3.85%-4.61%
Expected lives (in years)   5.00    5.00-5.50 
Weighted-average grant date fair value  $0.07   $0.06 
The following table sets forth information about the weighted-average fair value of options granted to non-employees during the year, using the Black Scholes option-pricing model and the weighted-average assumptions used for such grants:
   For the
nine months ended
September 30,
 
   2024   2023 
Weighted-average fair value of underlying stock at grant date   
   $0.07 
Dividend yields   
    
 
Expected volatility   
    134%
Risk-free interest rates   
    4.1%
Expected lives (in years)   
    10 
Weighted-average grant date fair value   
   $0.05 

 

Schedule of Compensation Cost of Warrant and Option Issuances The following table sets forth information about the compensation cost of warrant and option issuances recognized for employees and directors:
For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  101       264  
 For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  331       921  
The following table sets forth information about the compensation cost of warrant and option issuances recognized for non-employees:
For the three months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  1        
For the nine months ended September 30,  
2024     2023  
US$ thousands     US$ thousands  
  3       2  

 

Schedule of Warrants Transactions The warrants balances at December 31, 2023 and transactions since January 1, 2024 are shown in the table below:
Warrants  Exercise
Price
   Warrant
Termination
Date
  Outstanding
Balance,
12/31/2023
   Warrants
Issued
   Warrants
Exercised
   Warrants
Expired
   Outstanding
Balance,
09/30/2024
 
ZNWAA  $2.00   01/31/2025   1,498,804    
      -
    
       -
    
-
    1,498,804 
ZNWAG  $1.00   01/08/2024   240,068    
-
    
-
    (240,068)   
-
 
ZNWAM  $0.05   12/31/2024   4,376,000    
-
    
-
    
-
    4,376,000 
ZNWAQ  $0.05   12/31/2024   23,428,348    
-
    
-
    
-
    23,428,348 
ZNWAZ  $0.25   07/17/2024   153,800         
-
    (153,800)   
-
 
Outstanding warrants           29,697,020    
-
    
-
    (393,868)   29,303,152 

 

Schedule of Warrants with an Expiration The price and the expiration dates for the series of warrants to investors are shown in the table below. The listing contains only those warrants with a future expiration date.
      Period of Grant   US$   Expiration Date
ZNWAA Warrants  A,B,E,H   March 2013 – December 2014    2.00   January 31, 2025
ZNWAM Warrants  C,F,I,J   January 2021 – March 2021    0.05   December 31, 2024
ZNWAQ Warrants  C,F,I,J   June 2021    0.05   December 31, 2024
ZNWAS Warrants  D   August 2021 – March 2022    0.25   December 31, 2025
ZNWAT Warrants  D   August – September 2022    0.25   December 31, 2025
ZNWAU Warrants  D   October – November 2022    0.25   December 31, 2025
ZNWBA Warrants  G,K   November – December 2024    0.25   January 31, 2026
A On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
   
B On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
   
C On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
   
D These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
   
E On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
   
F The warrant exercise price was lowered to $0.05 on December 28, 2022.
   
G On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.
H On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.
I On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.
J On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
   
K

On May 29, 2024, the Company filed Amendment No. 10 whereby the current unit option was extended to August 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On August 22, 2024, the Company filed Amendment No. 11 whereby the current unit option was extended to October 15, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended.  On October 9, 2024, the Company filed Amendment No. 12 whereby the current unit option was extended to December 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended to January 31, 2026.

v3.24.3
Unproved Oil and Gas Properties, Full Cost Method (Tables)
9 Months Ended
Sep. 30, 2024
Unproved Oil and Gas Properties, Full Cost Method [Abstract]  
Schedule of Unproved Oil and Gas Properties Unproved oil and gas properties, under the full cost method, are comprised as follows:
   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Excluded from amortization base:        
Drilling costs, and other operational related costs   6,050    2,538 
Capitalized salary costs   2,521    2,444 
Capitalized interest costs   1,418    1,418 
Legal and seismic costs, license fees and other preparation costs   11,005    10,198 
Other costs   39    39 
    21,033    16,637 
Schedule of Post Impairment of Unproved Oil and Gas Properties Post Impairment of unproved oil and gas properties comprised as follows:
   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   
     -
    20    
     -
    76 
Capitalized salary costs   
-
    
-
    
-
    
-
 
Capitalized interest costs   
-
    
-
    
-
    
-
 
Legal costs, license fees and other preparation costs   
-
    16    
-
    53 
Other costs   
-
    
-
    
-
    
-
 
    
-
    36    
-
    129 
Schedule of Changes in Unproved Oil and Gas Properties Changes in Unproved oil and gas properties during the three and nine months ended September 30, 2024 and 2023 are as follows:
   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2024   2023   2024   2023 
   US$
thousands
   US$
thousands
   US$
thousands
   US$
thousands
 
Excluded from amortization base:                
Drilling costs, and other operational related costs   2,865    58    3,512    204 
Capitalized salary costs   26    25    77    77 
Capitalized interest costs   
-
    
-
    -    - 
Legal and seismic costs, license fees and other preparation costs   327    103    807    301 
Other costs   
-
    
-
    -    - 
Impairment of unproved oil and gas properties   
-
    (36)   -    (129)
    *3,218    *150    *4,396    *453 
* Inclusive of non-cash amounts of approximately $146,000, and $129,000 during the three months ended September 30, 2024, and 2023, respectively
   
* Inclusive of non-cash amounts of approximately $856,000, and $677,000 during the nine months ended September 30, 2024, and 2023, respectively
v3.24.3
Right of Use Lease Assets and Lease Obligations (Tables)
9 Months Ended
Sep. 30, 2024
Right of Use Lease Assets and Lease Obligations [Abstract]  
Schedule of Operating Lease Assets and Liabilities The table below presents the operating lease assets and liabilities recognized on the balance sheet as of September 30, 2024 and December 31, 2023:
   September 30,
2024
   December 31,
2023
 
   US$
thousands
   US$
thousands
 
Operating lease assets  $826   $194 
           
Operating lease liabilities:          
Current operating lease liabilities  $145   $167 
Non-current operating lease liabilities  $652   $24 
Total operating lease liabilities  $797   $191 
Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate The Company’s weighted average remaining lease term and weighted average discount rate for operating leases as of September 30, 2024 are:
   September 30,
2024
 
Weighted average remaining lease term (years)   5.9 
Weighted average discount rate   7.8%

 

Schedule of Future Minimum Lease Payments The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancellable operating leases with terms of more than one year to the total operating lease liabilities recognized on the condensed balance sheets as of September 30, 2024:
    US$
thousands
 
2024    49 
2025    155 
2026    151 
2027    149 
2028    149 
Thereafter    346 
Total undiscounted future minimum lease payments    999 
Less: portion representing imputed interest    (202)
Total undiscounted future minimum lease payments    797 
v3.24.3
Nature of Operations, Basis of Presentation and Going Concern (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 14, 2023
a
Sep. 30, 2024
USD ($)
ft²
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
ft²
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Sep. 14, 2023
km²
Nature of Operations, Basis of Presentation and Going Concern [Line Items]              
Net loss   $ (1,791) $ (1,743) $ (5,617) $ (6,216)    
Accumulated deficit   $ (292,176)   $ (292,176)   $ (286,559)  
New Megiddo Valleys License [Member]              
Nature of Operations, Basis of Presentation and Going Concern [Line Items]              
Number of Years License Maturity Term 7 years            
MJ-01 Project [Member]              
Nature of Operations, Basis of Presentation and Going Concern [Line Items]              
Area of land | ft²   2,050   2,050      
MJ-01 Project [Member] | New Megiddo Valleys License [Member]              
Nature of Operations, Basis of Presentation and Going Concern [Line Items]              
Area of land 75,000           302
v3.24.3
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Jun. 07, 2023
Mar. 12, 2020
Summary of Significant Accounting Policies [Line Items]              
Common stock, par value (in Dollars per share) $ 0.01   $ 0.01   $ 0.01 $ 0.01  
Diluted net loss per share (in Shares)     33,337,132 27,096,250      
Post-impairment charges $ 36 $ 129      
Capitalized exploration costs     $ 21,033,000   $ 16,637,000    
Related equipment and spare parts purchase price             $ 5,600
Allocated in spare parts             540,000
Allocated in additional separate assets             $ 48,000
Useful life 5 years   5 years        
I-35 Drilling Rig [Member]              
Summary of Significant Accounting Policies [Line Items]              
Useful life             10 years
Rig Spare Parts [Member]              
Summary of Significant Accounting Policies [Line Items]              
Purchased of other asset     $ 178,000        
Drilling Pipe and Accessories [Member]              
Summary of Significant Accounting Policies [Line Items]              
Sold of other asset     $ 35,000        
Warrant [Member]              
Summary of Significant Accounting Policies [Line Items]              
Diluted net loss per share (in Shares)     29,303,152 30,242,620      
v3.24.3
Summary of Significant Accounting Policies (Details) - Schedule of Drilling Rig & Associated Equipment - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Balance Beginning $ 5,510 $ 6,281
Asset Additions 178
Asset Depreciation (594) (751)
Asset Disposals (97)  
Asset Disposals for Self-Consumption (39) (11)
Balance Ending 4,958 5,510
I-35 Drilling Rig [Member]    
Property, Plant and Equipment [Line Items]    
Balance Beginning 4,591 5,225
Asset Additions
Asset Depreciation (476) (634)
Asset Disposals  
Asset Disposals for Self-Consumption
Balance Ending 4,115 4,591
Rig Spare Parts [Member]    
Property, Plant and Equipment [Line Items]    
Balance Beginning 608 619
Asset Additions 178
Asset Depreciation
Asset Disposals  
Asset Disposals for Self-Consumption (39) (11)
Balance Ending 747 608
Other Drilling Assets [Member]    
Property, Plant and Equipment [Line Items]    
Balance Beginning 311 437
Asset Additions
Asset Depreciation (118) (117)
Asset Disposals (97)  
Asset Disposals for Self-Consumption
Balance Ending $ 96 $ 311
v3.24.3
Stockholders’ Equity (Details) - Part-1 - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Jun. 07, 2023
Stockholders’ Equity (Details) - Part-1 [Line Items]      
Common stock par value $ 0.01 $ 0.01 $ 0.01
Shares authorized (in Shares) 1,200,000,000 1,200,000,000  
Minimum [Member]      
Stockholders’ Equity (Details) - Part-1 [Line Items]      
Shares authorized (in Shares)     800,000,000
Maximum [Member]      
Stockholders’ Equity (Details) - Part-1 [Line Items]      
Shares authorized (in Shares)     1,200,000,000
v3.24.3
Stockholders’ Equity (Details) - Part-2 - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 01, 2024
Dec. 14, 2022
Mar. 21, 2022
Jun. 09, 2021
Sep. 15, 2020
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2021
Dec. 31, 2024
Jun. 30, 2022
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)               10,000,000          
Exercise price           $ 1   $ 1          
Extended termination term     1 year                    
Number of shares purchase (in Shares)               1          
Net cash (in Dollars)                         $ 365,000
Equity issuance costs (in Dollars)           $ 536,000 $ 610,000 $ 2,299,000 $ 437,000 $ 1,120,000      
Price per share           $ 250   $ 250          
Purchase stock amount (in Dollars) $ 10,000,000                        
Dividend reinvestment and stock purchase plan interest               65.00%          
ZNWAD [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term         2 years                
Extended termination term,description               expiration date of May 2, 2021 to May 2, 2023          
ZNWAE Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term               2 years          
Extended termination term,description               expiration date of May 1, 2021 to May 1, 2023          
ZNWAF Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term               2 years          
Extended termination term,description               expiration date of August 14, 2021 to August 14, 2023          
ZNWAG Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term   1 year                      
Extended termination term,description               expiration date of January 8, 2023 to January 8, 2024          
ZNWAH Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term         2 years                
Extended termination term,description               expiration date of April 2, 2021 to April 2, 2023          
ZNWAJ Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term               2 years          
Extended termination term,description               expiration date of October 29, 2021 to October 29, 2023          
ZNWAK Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term               2 years          
Extended termination term,description               expiration date of February 25, 2021 to February 25, 2023          
ZNWAL Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term               2 years          
Extended termination term,description               expiration date of August 26, 2021 to August 26, 2023          
ZNWAM Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Exercise price           0.05   $ 0.05          
Extended termination term               1 year          
Extended termination term,description               expiration date of July 15, 2022 to July 15, 2023          
Warrant exercise price           1   $ 1          
ZNWAO Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   0.25          
ZNWAP Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   0.25          
Znwap Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term     1 year                    
Net cash (in Dollars)                         $ 365,000
ZNWAQ Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.05   $ 0.05          
Number of shares purchase (in Shares)               1          
ZNWAR Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   $ 0.25          
Number of shares purchase (in Shares)               1          
Equity issuance costs (in Dollars)                     $ 115,000    
ZNWAS Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   $ 0.25          
Number of shares purchase (in Shares)               1          
ZNWAT Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   $ 0.25          
Number of shares purchase (in Shares)               1          
ZNWAU Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   $ 0.25          
Number of shares purchase (in Shares)               1          
Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price $ 0.25         0.25   $ 0.25          
Pro rata issuance warrant (in Shares) 10,000,000                        
Common Stock [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Extended termination term     1 year                    
Number of shares purchase (in Shares)               1          
2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Number of shares issued (in Shares)       38,000,000                  
Options exercisable term       10 years                  
Fair value of stock options granted (in Dollars)               $ 11,000          
Five senior officers and two staff members [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)               175,000          
Exercise price           0.07   $ 0.07          
One Senior Officer [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)               25,000 25,000        
Exercise price           0.01 $ 0.01 $ 0.01 $ 0.01        
Fair value of stock options granted (in Dollars)               $ 1,800 $ 1,500        
One Staff [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)               10,000 10,000        
Exercise price           0.01 0.01 $ 0.01 $ 0.01        
Fair value of stock options granted (in Dollars)               $ 500 $ 600        
Five Senior Officers and One Staff [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 175,000        
Exercise price             0.0615   $ 0.0615        
Fair value of stock options granted (in Dollars)                 $ 9,000        
One Board [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 25,000        
Exercise price             0.07   $ 0.07        
Fair value of stock options granted (in Dollars)                 $ 1,500        
Five Staff Members and One Senior Officer [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 895,000        
Exercise price             0.01   $ 0.01        
Fair value of stock options granted (in Dollars)                 $ 60,000        
Four Senior Officers and Nine Staff [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 3,350,000        
Exercise price             0.0676   $ 0.0676        
Fair value of stock options granted (in Dollars)                 $ 211,000        
Options vested date               Sep. 23, 2024          
Nine Board Members [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 3,600,000        
Exercise price             0.0676   $ 0.0676        
Fair value of stock options granted (in Dollars)                 $ 227,000        
Options vested date                 Sep. 23, 2024        
Three Consultants [Member] | 2021 Omnibus Incentive Stock Option Plan [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Shares purchased under option plan (in Shares)                 55,000        
Exercise price             $ 0.0676   $ 0.0676        
Fair value of stock options granted (in Dollars)                 $ 3,000        
Options vested date                 Sep. 23, 2024        
Common Stock [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Equity issuance costs (in Dollars)               $ 173,000          
Common Stock [Member] | ZNWAP Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   $ 0.25          
Common Stock [Member] | ZNWAQ Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   0.25          
Common Stock [Member] | ZNWAR Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   0.25          
Common Stock [Member] | ZNWAS Warrant [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           1   1          
Common Stock [Member] | ZNWAT Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           0.25   0.25          
Common Stock [Member] | ZNWAU Warrants [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Warrant exercise price           $ 0.25   $ 0.25          
Forecast [Member]                          
Stockholders’ Equity (Details) - Part-2 [Line Items]                          
Price per share                       $ 0.15  
v3.24.3
Stockholders’ Equity (Details) - Part-3 - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 13, 2023
Sep. 15, 2020
May 29, 2019
Dec. 04, 2018
Apr. 02, 2018
Nov. 06, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Jan. 15, 2025
Dec. 31, 2024
Jul. 17, 2024
Apr. 01, 2024
Jan. 10, 2024
Dec. 31, 2023
Sep. 10, 2023
Jul. 31, 2023
Jul. 13, 2023
Jun. 28, 2023
Jun. 07, 2023
Dec. 28, 2022
Dec. 14, 2022
Mar. 21, 2022
Jun. 29, 2020
May 19, 2019
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Dividend reinvestment and stock purchase plan percentage                   54.00%                                
Termination value. (in Dollars) $ 7,500,000                                                  
Price per share             $ 250   $ 250                                  
Number of shares purchase (in Shares)                 1                                  
Exercise price             1   $ 1                                  
Subscriptions receivable (in Dollars)           $ 1,319,000                                        
Equity issuance costs (in Dollars)               $ 437,000   $ 610,000                                
Common stock par value             0.01   $ 0.01             $ 0.01         $ 0.01          
ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.05   $ 0.05                                  
Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price             0.25   0.25         $ 0.25                        
ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   0.25                                  
Extension of Termination Date to March 31, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to March 31, 2024 [Member] | Automatic Monthly Investments ('' AMI'') Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Extension of Termination Date to March 31, 2024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to March 31, 2024 [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to April 30, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to April 30, 2024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to April 30, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to May 31, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to May 31, 2024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to May 31, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Extension of Termination Date to August 31, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to August 31, 2024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to August 31, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Extension of Termination Date to October 15, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to October 15, 2024 [Member] | Automatic Monthly Investments ('' AMI'') Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Extension of Termination Date to October 15, 2024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Extension of Termination Date to October 15, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Extension of Termination Date to December312024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Number of additional warrant (in Shares)                 50                                  
Warrant exercise price             $ 0.25   $ 0.25                         $ 0.05        
Subscriptions receivable (in Dollars)             $ 3,692,000 1,805,000 $ 12,160,000 4,358,000                                
Stock issuance costs (in Dollars)             3,692,000 $ 1,805,000 12,160,000 $ 4,358,000                                
Equity issuance costs (in Dollars)             536,000   2,299,000                                  
Net cash provided (in Dollars)             $ 3,156,000   $ 9,861,000                                  
Subscription price         $ 5                                          
Warrant expiration   2 years 1 year 1 year                                            
Number of share owned (in Shares)                 10                                  
Proceeds from Issuance Initial Public Offering (in Dollars)                 $ 3,038,000                                  
Warrant term   2 years                                                
Extension of Termination Date to December312024 [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Purchase shares of common stock (in Shares)             50   50                                  
Extension of Termination Date to December312024 [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price         3                                          
Warrant term                             1 year               1 year 1 year   1 year
Extension of Termination Date to December312024 [Member] | Subscription Rights Offering [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price                                                 $ 3  
Expenses from rights offering (in Dollars)                 $ 243,000                                  
Common Stock [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of shares purchase (in Shares)                 1                                  
Common Stock [Member] | Extension of Termination Date to December312024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Common stock par value         $ 0.01                                          
Unit Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of shares purchase (in Shares)                 500                                  
Amendment No. 2 New Unit Option under the Unit Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Purchased unit (in Shares)             1   1                                  
Warrants received (in Shares)                 500                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAY Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAY [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 500                                  
Debt Instrument, Increase (Decrease), Net (in Dollars)                 $ 50                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAY [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price             $ 0.05   $ 0.05                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrants received (in Shares)                 100                                  
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAY Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price                                 $ 0.05     $ 0.05            
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAW Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price                                     $ 0.05              
Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAX Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price                                   $ 0.05                
Amendment No. 2 New Unit Option under the Unit Program [Member] | Minimum [Member] | ZNWAY [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 100                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share             250   $ 250                                  
Number of additional warrant (in Shares)                 300                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | OTCQX warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | ZNWAZ Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price                         $ 0.25                          
Number of additional warrant (in Shares)                 300                                  
Warrant exercise price             0.25   $ 0.25                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | Znwak Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   0.25                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | Common Stock [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share             250   $ 250                                  
Amendment No. 3 New Unit Option under the Unit Program [Member] | Common Stock [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of shares purchase (in Shares)                 1                                  
Number of additional warrant (in Shares)                 200                                  
Amendment No. 4 New Unit Option under the Unit Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of shares purchase (in Shares)                 1                                  
Warrant exercise price             0.25   $ 0.25                                  
Amendment No. 4 New Unit Option under the Unit Program [Member] | O T C B [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share             0.25   $ 0.25                                  
Amendment No. 4 New Unit Option under the Unit Program [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Amendment No. 4 New Unit Option under the Unit Program [Member] | Common Stock [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share             250   $ 250                                  
Amendment No. 4 New Unit Option under the Unit Program [Member] | Common Stock [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Amendment No. 4 New Unit Option under the Unit Program [Member] | Common Stock [Member] | ZNWAZ Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price             0.25   $ 0.25                                  
Extension of Termination Date to December312024 [Member] | Automatic Monthly Investments ('' AMI'') Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Extension of Termination Date to December312024 [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Dividend Reinvestment and Common Stock Purchase Plan [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Dividend Reinvestment and Common Stock Purchase Plan [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Dividend Reinvestment and Common Stock Purchase Plan [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             0.25   $ 0.25                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to April 30, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to May 31, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to May 31, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to August 31, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to August 31, 2024 [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to October 15, 2024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Extension of Termination Date to December312024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Amendment No. 2 New Unit Option under the Unit Program [Member] | ZNWAY [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 250                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Amendment No. 3 New Unit Option under the Unit Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 300                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Amendment No. 3 New Unit Option under the Unit Program [Member] | Warrant [Member] | ZNWAZ Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Amendment No. 4 New Unit Option under the Unit Program [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
AMI minimum amount (in Dollars)                 $ 50                                  
Automatic Monthly Investments ('' AMI'') Program [Member] | Dividend Reinvestment and Common Stock Purchase Plan [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Unit Option Program [Member] | Amendment No. 3 New Unit Option under the Unit Program [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share             250   $ 250                                  
ZNWAE warrants [Member] | Amendment No. 4 New Unit Option under the Unit Program [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Unit Option [Member] | Extension of Termination Date to December312024 [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Warrant exercise price             0.25   $ 0.25                                  
Unit Option [Member] | Dividend Reinvestment and Common Stock Purchase Plan [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Unit Option [Member] | Automatic Monthly Investments ('' AMI'') Program [Member] | Warrant [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Number of additional warrant (in Shares)                 50                                  
Common Stock [Member] | Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price             $ 0.05   $ 0.05                                  
Forecast [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Price per share                       $ 0.15                            
Forecast [Member] | Amendment No. 4 New Unit Option under the Unit Program [Member] | ZNWBA Warrants [Member]                                                    
Stockholders’ Equity (Details) - Part-3 [Line Items]                                                    
Exercise price                     $ 0.25                              
v3.24.3
Stockholders’ Equity (Details) - Schedule of Stock Option Transactions - Employee Stock [Member] - $ / shares
9 Months Ended
Sep. 30, 2024
Stockholders’ Equity (Details) - Schedule of Stock Option Transactions [Line Items]  
Number of shares, Outstanding, Beginning balance 34,091,250
Weighted Average exercise price, Outstanding, Beginning balance $ 0.23
Changes during 2024 to:  
Number of shares, Granted to employees, officers, directors and others 210,000
Weighted Average exercise price, Granted to employees, officers, directors and others $ 0.07
Number of shares, Expired/Cancelled/Forfeited (825,943)
Weighted Average exercise price, Expired/Cancelled/Forfeited $ 1.72
Number of shares, Exercised (138,175)
Weighted Average exercise price, Exercised $ 0.07
Number of shares, Outstanding, Ending balance 33,337,132
Weighted Average exercise price, Outstanding, Ending balance $ 0.19
Number of shares, Exercisable 33,337,132
Weighted Average exercise price, Exercisable $ 0.19
v3.24.3
Stockholders’ Equity (Details) - Schedule of Stock Options Outstanding
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares
Weighted Average Exercise price
Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number outstanding (in Shares) | shares 33,337,132
Weighted Average Exercise price $ 0.19
Minimum [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 0.01
Maximum [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price 1.38
Ranges One [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 107,500
Weighted average remaining contractual life (years) 2 years 3 months
Weighted Average Exercise price $ 0.01
Ranges Two [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 2 years 3 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Three [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 60,000
Weighted average remaining contractual life (years) 2 years 6 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Four [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 3 years 7 months 20 days
Weighted Average Exercise price $ 0.01
Ranges Five [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 40,000
Weighted average remaining contractual life (years) 3 years
Weighted Average Exercise price $ 0.01
Ranges Six [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 70,000
Weighted average remaining contractual life (years) 3 years 3 months
Weighted Average Exercise price $ 0.01
Ranges Seven [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 3 years 3 months 3 days
Weighted Average Exercise price $ 0.01
Ranges Eight [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 30,000
Weighted average remaining contractual life (years) 3 years 4 months 28 days
Weighted Average Exercise price $ 0.01
Ranges Nine [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 4,000
Weighted average remaining contractual life (years) 3 years 6 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Ten [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Ten [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 4 years 3 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Eleven [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eleven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 35,000
Weighted average remaining contractual life (years) 5 years 11 months 19 days
Weighted Average Exercise price $ 0.01
Ranges Twelve [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twelve [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 150,000
Weighted average remaining contractual life (years) 5 years 1 month 20 days
Weighted Average Exercise price $ 0.01
Ranges Thirteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 35,000
Weighted average remaining contractual life (years) 4 years 11 months 19 days
Weighted Average Exercise price $ 0.01
Ranges Fourteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 6 years 3 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Fifteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price $ 0
Ranges Fifteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 200,000
Weighted average remaining contractual life (years) 6 years 7 months 20 days
Weighted Average Exercise price $ 0.01
Ranges Sixteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Sixteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 300,000
Weighted average remaining contractual life (years) 6 years 9 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Seventeen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Seventeen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 6 years 11 months 1 day
Weighted Average Exercise price $ 0.01
Ranges Eighteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Eighteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 500,000
Weighted average remaining contractual life (years) 7 years 3 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Nineteen [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Nineteen [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 55,000
Weighted average remaining contractual life (years) 7 years 3 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Twenty [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 960,000
Weighted average remaining contractual life (years) 7 years 6 months 18 days
Weighted Average Exercise price $ 0.01
Ranges Twenty One [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 7 years 10 months 13 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Two [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 7 years 11 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Three [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 795,000
Weighted average remaining contractual life (years) 7 years 11 months 26 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Four [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 8 years 3 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Five [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 8 years 11 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Six [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 895,000
Weighted average remaining contractual life (years) 8 years 11 months 23 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Seven [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 9 years 3 months 7 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Eight [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.01
Number outstanding (in Shares) | shares 10,000
Weighted average remaining contractual life (years) 9 years 11 months 4 days
Weighted Average Exercise price $ 0.01
Ranges Twenty Nine [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Twenty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.06
Number outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 8 years 3 months 7 days
Weighted Average Exercise price $ 0.06
Ranges Thirty [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number outstanding (in Shares) | shares 125,000
Weighted average remaining contractual life (years) 9 years 3 months 7 days
Weighted Average Exercise price $ 0.07
Ranges Thirty One [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.07
Number outstanding (in Shares) | shares 6,980,000
Weighted average remaining contractual life (years) 8 years 11 months 26 days
Weighted Average Exercise price $ 0.07
Ranges Thirty Two [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.14
Number outstanding (in Shares) | shares 210,000
Weighted average remaining contractual life (years) 7 years 3 months 18 days
Weighted Average Exercise price $ 0.14
Ranges Thirty Three [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number outstanding (in Shares) | shares 3,200,000
Weighted average remaining contractual life (years) 7 years 3 months 7 days
Weighted Average Exercise price $ 0.15
Ranges Thirty Four [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.15
Number outstanding (in Shares) | shares 6,354,325
Weighted average remaining contractual life (years) 7 years 6 months 18 days
Weighted Average Exercise price $ 0.15
Ranges Thirty Five [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number outstanding (in Shares) | shares 340,000
Weighted average remaining contractual life (years) 1 year 2 months 8 days
Weighted Average Exercise price $ 0.16
Ranges Thirty Six [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.16
Number outstanding (in Shares) | shares 75,000
Weighted average remaining contractual life (years) 5 years 2 months 12 days
Weighted Average Exercise price $ 0.16
Ranges Thirty Seven [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.18
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 1 year 2 months 1 day
Weighted Average Exercise price $ 0.18
Ranges Thirty Eight [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.18
Number outstanding (in Shares) | shares 5,130,000
Weighted average remaining contractual life (years) 7 years 11 months 26 days
Weighted Average Exercise price $ 0.18
Ranges Thirty Nine [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Thirty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.24
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 7 years 10 months 2 days
Weighted Average Exercise price $ 0.24
Ranges Fourty [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.24
Number outstanding (in Shares) | shares 118,000
Weighted average remaining contractual life (years) 7 years 10 months 13 days
Weighted Average Exercise price $ 0.24
Ranges Fourty One [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number outstanding (in Shares) | shares 50,000
Weighted average remaining contractual life (years) 6 years 11 months 1 day
Weighted Average Exercise price $ 0.25
Ranges Fourty Two [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Two [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.25
Number outstanding (in Shares) | shares 363,000
Weighted average remaining contractual life (years) 6 years 11 months 1 day
Weighted Average Exercise price $ 0.25
Ranges Fourty Three [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Three [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 11 months 4 days
Weighted Average Exercise price $ 0.28
Ranges Fourty Four [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Four [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.28
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 4 years 11 months 4 days
Weighted Average Exercise price $ 0.28
Ranges Fourty Five [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Five [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.29
Number outstanding (in Shares) | shares 25,000
Weighted average remaining contractual life (years) 2 years 8 months 15 days
Weighted Average Exercise price $ 0.29
Ranges Fourty Six [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Six [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.39
Number outstanding (in Shares) | shares 1,435,000
Weighted average remaining contractual life (years) 6 years 9 months 10 days
Weighted Average Exercise price $ 0.39
Ranges Fourty Seven [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Seven [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number outstanding (in Shares) | shares 1,400,000
Weighted average remaining contractual life (years) 2 years 7 months 20 days
Weighted Average Exercise price $ 0.59
Ranges Fourty Eight [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Eight [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.59
Number outstanding (in Shares) | shares 1,600,000
Weighted average remaining contractual life (years) 6 years 7 months 20 days
Weighted Average Exercise price $ 0.59
Ranges Fourty Nine [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fourty Nine [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number outstanding (in Shares) | shares 350,000
Weighted average remaining contractual life (years) 2 years 3 months 3 days
Weighted Average Exercise price $ 0.92
Ranges Fifty [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 0.92
Number outstanding (in Shares) | shares 550,000
Weighted average remaining contractual life (years) 6 years 3 months 7 days
Weighted Average Exercise price $ 0.92
Ranges Fifty One [Member] | Non-Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price
Number outstanding (in Shares) | shares
Weighted average remaining contractual life (years)
Weighted Average Exercise price
Ranges Fifty One [Member] | Vested [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of exercise price $ 1.38
Number outstanding (in Shares) | shares 105,307
Weighted average remaining contractual life (years) 3 months 3 days
Weighted Average Exercise price $ 1.38
v3.24.3
Stockholders’ Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted - $ / shares
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Employees and Directors [Member]    
Stockholders’ Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted [Line Items]    
Weighted-average fair value of underlying stock at grant date (in Dollars per share) $ 0.07 $ 0.07
Dividend yields
Expected lives (in years) 5 years  
Weighted-average grant date fair value (in Dollars per share) $ 0.07 $ 0.06
Non-Employees [Member]    
Stockholders’ Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted [Line Items]    
Weighted-average fair value of underlying stock at grant date (in Dollars per share) $ 0.07
Dividend yields
Expected volatility 134.00%
Risk-free interest rates 4.10%
Expected lives (in years) 10 years
Weighted-average grant date fair value (in Dollars per share) $ 0.05
Minimum [Member] | Employees and Directors [Member]    
Stockholders’ Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted [Line Items]    
Expected volatility 133.00% 135.00%
Risk-free interest rates 3.71% 3.85%
Expected lives (in years)   5 years
Maximum [Member] | Employees and Directors [Member]    
Stockholders’ Equity (Details) - Schedule of Weighted-Average Fair Value of Options Granted [Line Items]    
Expected volatility 134.00% 137.00%
Risk-free interest rates 3.97% 4.61%
Expected lives (in years)   5 years 6 months
v3.24.3
Stockholders’ Equity (Details) - Schedule of Compensation Cost of Warrant and Option Issuances - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Employees and Directors [Member]        
Stockholders’ Equity (Details) - Schedule of Compensation Cost of Warrant and Option Issuances [Line Items]        
Compensation cost of warrant and option issuances $ 101 $ 264 $ 331 $ 921
Non-Employees [Member]        
Stockholders’ Equity (Details) - Schedule of Compensation Cost of Warrant and Option Issuances [Line Items]        
Compensation cost of warrant and option issuances $ 1 $ 3 $ 2
v3.24.3
Stockholders’ Equity (Details) - Schedule of Warrants Transactions
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Outstanding Balance, Beginning 29,697,020
Warrants Issued
Warrants Exercised
Outstanding Balance, Ending 29,303,152
Warrants Expired (393,868)
Warrant Transactions [Member] | ZNWAA [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 2
Warrant Termination Date Jan. 31, 2025
Outstanding Balance, Beginning 1,498,804
Warrants Issued
Warrants Exercised
Outstanding Balance, Ending 1,498,804
Warrants Expired
Warrant Transactions [Member] | ZNWAG [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 1
Warrant Termination Date Jan. 08, 2024
Outstanding Balance, Beginning 240,068
Warrants Issued
Warrants Exercised
Outstanding Balance, Ending
Warrants Expired (240,068)
Warrant Transactions [Member] | ZNWAM [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.05
Warrant Termination Date Dec. 31, 2024
Outstanding Balance, Beginning 4,376,000
Warrants Issued
Warrants Exercised
Outstanding Balance, Ending 4,376,000
Warrants Expired
Warrant Transactions [Member] | ZNWAQ [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.05
Warrant Termination Date Dec. 31, 2024
Outstanding Balance, Beginning 23,428,348
Warrants Issued
Warrants Exercised
Outstanding Balance, Ending 23,428,348
Warrants Expired
Warrant Transactions [Member] | ZNWAZ [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants Transactions [Line Items]  
Exercise Price (in Dollars per share) | $ / shares $ 0.25
Warrant Termination Date Jul. 17, 2024
Outstanding Balance, Beginning 153,800
Warrants Exercised
Outstanding Balance, Ending
Warrants Expired (153,800)
v3.24.3
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration - Investor [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
Znwaa Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant March 2013 – December 2014 [1],[2],[3],[4]
Exercise Price $ 2 [1],[2],[3],[4]
Expiration Date January 31, 2025 [1],[2],[3],[4]
Znwam Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant January 2021 – March 2021 [5],[6],[7],[8]
Exercise Price $ 0.05 [5],[6],[7],[8]
Expiration Date December 31, 2024 [5],[6],[7],[8]
ZNWAQ Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant June 2021 [5],[6],[7],[8]
Exercise Price $ 0.05 [5],[6],[7],[8]
Expiration Date December 31, 2024 [5],[6],[7],[8]
Znwas Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant August 2021 – March 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
Znwat Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant August – September 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
ZNWAU Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant October – November 2022 [9]
Exercise Price $ 0.25 [9]
Expiration Date December 31, 2025 [9]
ZNWBA Warrants [Member]  
Stockholders’ Equity (Details) - Schedule of Warrants with an Expiration [Line Items]  
Period of Grant November – December 2024 [10],[11]
Exercise Price $ 0.25 [10],[11]
Expiration Date January 31, 2026 [10],[11]
[1] On December 14, 2022, the Company extended the expiration date of the Warrants by one (1) year.
[2] On January 10, 2024, the Company extended the expiration date of the ZNWAA warrant by one (1) year.
[3] On May 29, 2019, the Company extended the expiration date of the Warrants by one (1) year.
[4] On September 15, 2020, the Company extended the expiration date of the Warrants by two (2) years.
[5] On December 18, 2023, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to March 31, 2024.
[6] On March 21, 2022, the Company extended the expiration date of the Warrants by one (1) year. On June 16, 2023, the Company extended the expiration date of the Warrants to September 6, 2023. On August 21, 2023, the Company extended the expiration date of the Warrants to October 31, 2023. On October 19, 2023, the Company extended the expiration date of the Warrants to December 31, 2023.
[7] On March 23, 2024, the Company extended the expiration date of the ZNWAM and ZNWAQ warrants to December 31, 2024.
[8] The warrant exercise price was lowered to $0.05 on December 28, 2022.
[9] These warrants will be issued and become exercisable beginning on November 15, 2025 and expire on December 31, 2025.
[10] On November 6, 2023 the Company announced a new Unit Offering and the related ZNWBA warrant.
[11] On May 29, 2024, the Company filed Amendment No. 10 whereby the current unit option was extended to August 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended. On August 22, 2024, the Company filed Amendment No. 11 whereby the current unit option was extended to October 15, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended.  On October 9, 2024, the Company filed Amendment No. 12 whereby the current unit option was extended to December 31, 2024 and the exercise date and termination date of the related ZNWBA warrants were also extended to January 31, 2026.
v3.24.3
Unproved Oil and Gas Properties, Full Cost Method (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Unproved Oil and Gas Properties, Full Cost Method [Abstract]        
Non-cash amounts $ 146,000 $ 129,000 $ 856,000 $ 677,000
v3.24.3
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Unproved Oil and Gas Properties - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Excluded from amortization base:    
Drilling costs, and other operational related costs $ 6,050 $ 2,538
Capitalized salary costs 2,521 2,444
Capitalized interest costs 1,418 1,418
Legal and seismic costs, license fees and other preparation costs 11,005 10,198
Other costs 39 39
Unproved oil and gas properties, full cost method $ 21,033 $ 16,637
v3.24.3
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Post Impairment of Unproved Oil and Gas Properties - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Excluded from amortization base:        
Drilling costs, and other operational related costs $ 20 $ 76
Capitalized salary costs
Capitalized interest costs
Legal costs, license fees and other preparation costs 16 53
Other costs
Total of post impairment of unproved oil and gas properties $ 36 $ 129
v3.24.3
Unproved Oil and Gas Properties, Full Cost Method (Details) - Schedule of Changes in Unproved Oil and Gas Properties - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Excluded from amortization base:        
Drilling costs, and other operational related costs $ 2,865 $ 58 $ 3,512 $ 204
Capitalized salary costs 26 25 77 77
Capitalized interest costs    
Legal and seismic costs, license fees and other preparation costs 327 103 807 301
Other costs    
Impairment of unproved oil and gas properties (36)   (129)
Total unproved oil and gas properties $ 3,218 [1] $ 150 [1] $ 4,396 [2] $ 453 [2]
[1] Inclusive of non-cash amounts of approximately $146,000, and $129,000 during the three months ended September 30, 2024, and 2023, respectively
[2] Inclusive of non-cash amounts of approximately $856,000, and $677,000 during the nine months ended September 30, 2024, and 2023, respectively
v3.24.3
Right of Use Lease Assets and Lease Obligations (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
ft²
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
ft²
Sep. 30, 2023
USD ($)
Right of Use Lease Assets and Lease Obligations [Line Items]        
Lease agreement description     The Company had an option to renew the lease for another five years from February 1, 2024 to January 31, 2029, provided it is not in breach of the agreement, where it is required as well to furnish a notice of intent to exercise the option six months prior to termination of lease, and it furnishes a bank guarantee and insurance confirmation prior to commencement of the option period. The Company exercised the option to renew the lease for another seven years from February 1, 2024 through January 31, 2031, when rent is to be paid on a monthly basis in the base amount of approximately NIS 46,500 per month (approximately $12,500) at the exchange rate in effect on the date of this report and is linked to an increase (but not a decrease) in the CPI.  
Operating lease costs $ 75,000 $ 76,000 $ 224,000 $ 203,000
Operating lease liabilities   829,000  
Use Rights [Member]        
Right of Use Lease Assets and Lease Obligations [Line Items]        
Operating lease liabilities $ 55,000   $ 223,000  
Right-of-use assets obtained in exchange   252,000   252,000
Use Rights [Member]        
Right of Use Lease Assets and Lease Obligations [Line Items]        
Operating lease liabilities   $ 76,000   $ 203,000
Caesarea, Israel [Member]        
Right of Use Lease Assets and Lease Obligations [Line Items]        
Number of square feet (in Square Feet) | ft² 6,566   6,566  
v3.24.3
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Operating Lease Assets and Liabilities - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Schedule of Operating Lease Assets and Liabilities [Abstract]    
Operating lease assets $ 826 $ 194
Operating lease liabilities:    
Current operating lease liabilities 145 167
Non-current operating lease liabilities 652 24
Total operating lease liabilities $ 797 $ 191
v3.24.3
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate
Sep. 30, 2024
Schedule of Weighted Average Remaining Lease Term and Weighted Average Discount Rate for Operating Leases [Abstract]  
Weighted average remaining lease term (years) 5 years 10 months 24 days
Weighted average discount rate 7.80%
v3.24.3
Right of Use Lease Assets and Lease Obligations (Details) - Schedule of Future Minimum Lease Payments - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Schedule of Future Minimum Lease Payments [Abstract]    
2024 $ 49  
2025 155  
2026 151  
2027 149  
2028 149  
Thereafter 346  
Total undiscounted future minimum lease payments 999  
Less: portion representing imputed interest (202)  
Total undiscounted future minimum lease payments $ 797 $ 191
v3.24.3
Commitments and Contingencies (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Apr. 12, 2024
Feb. 23, 2024
Jan. 28, 2024
Dec. 16, 2023
Dec. 13, 2023
Nov. 16, 2023
Sep. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Mar. 12, 2024
Dec. 28, 2023
Commitments and Contingencies [Line Items]                      
Accrued license                  
Total premiums, taxes and fees           $ 76,263       $ 94,989 $ 441,598
Cash down payment   $ 37,637     $ 68,733 $ 22,699          
Insurance financing, payments $ 9,499   $ 37,287 $ 5,356              
Rate of interest 13.99%   13.40% 13.99%              
Due month 10 months   10 months 10 months              
Outstanding amount, insurance financing             $ 75,000 75,000 $ 432,000    
Bank guarantees to government             971,000 971,000      
Bank guarantees to others             91,000 91,000      
Bank guarantee amount             1,062,000 $ 1,062,000      
Percentage of currency inflation               2.30% 3.10%    
Cash, cash equivalents and short-term bank deposits             $ 1,847,000 $ 1,847,000      
Fund interest rate percentage             2.80% 2.90%      
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Four Suppliers [Member]                      
Commitments and Contingencies [Line Items]                      
Concentration of credit risk               10.00%      
Supplier Concentration Risk [Member] | Accounts Payable [Member] | Three Suppliers [Member]                      
Commitments and Contingencies [Line Items]                      
Concentration of credit risk               10.00%      
v3.24.3
Subsequent Events (Details)
1 Months Ended
Nov. 06, 2024
USD ($)
Subsequent Event [Member] | DSPP Program [Member]  
Subsequent Events [Line Items]  
Amount collected $ 1,319,000

Zion Oil and Gas (PK) (USOTC:ZNOGW)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Zion Oil and Gas (PK).
Zion Oil and Gas (PK) (USOTC:ZNOGW)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Zion Oil and Gas (PK).